International Journal of Nutrology
https://ijn.zotarellifilhoscientificworks.com/index.php/ijn
<div class="row"> <div class="col-lg-2 journal-front"> <div class="journal-front-section-title-left"> </div> <img src="https://ijn.zotarellifilhoscientificworks.com/public/journals/1/journalThumbnail_en_US.jpg" alt="" width="150" height="211" /></div> <div class="col-lg-7 journal-front"> <div class="journal-front-section-title-left">Aim & Scope</div> <p>The <strong>International Journal of Nutrology (IJN)</strong> is quarterly, established in 2011, open-access, and peer-reviewed, with the scope of publishing articles that cover nutrology and all medical specialties that are also interconnected with nutrological care and nutritional and dietary interventions in the context of prevention disease and health benefits. The IJN also encourages the publication of clinical, pre-clinical, and experimental studies on prophylaxis and different types of treatment for obesity.<br />Furthermore, randomized clinical, epidemiological, and public health studies relevant to human nutrition and investigations employing epigenetic, genomic, proteomic, and metabolomic approaches are encouraged. The IJN publishes human, animal, and laboratory studies, accepting original articles, review articles, case reports, and letters to the Editor, and publishing supplements and special editions.</p> <p><strong><span class="marginRight1 left" style="font-size: 0.875rem;">Years currently covered by Elsevier/Scopus: </span><span class="right" style="font-size: 0.875rem;">from 2019 to 2025.</span></strong></p> <p>IJN requires that authors follow the ICMJE (International Committee of Medical Journal Editors) recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals. More information can be found here: <a href="http://www.icmje.org">ICMJE</a></p> </div> <div class="col-lg-3 journal-front"> <div class="journal-front-section-title">Journal Description</div> <div class="front-lef"> <p>Title: <strong> International Journal of Nutrology</strong> <br />E-ISSN: <strong><a title="2595-2854" href="https://portal.issn.org/resource/ISSN/2595-2854" target="_blank" rel="noopener">2595-2854</a></strong> <br />P-ISSN: <strong><a href="https://portal.issn.org/resource/ISSN/1984-3011" target="_blank" rel="noopener">1984-3011</a></strong><br />Journal Abbreviation: <strong>Int. J. Nutrology</strong><br />Publication language: <strong>English</strong> <br />Publishing frequency: <strong>Quarterly</strong><br />DOI Prefix: <strong><a title="10.54448" href="https://api.crossref.org/prefixes/10.54448/works" target="_blank" rel="noopener">10.54448</a></strong></p> <div class="journal-front-section-title">Social Network</div> <div class="front-lef"><center><a href="https://www.facebook.com/zotarellifilhoscientificworks" target="_blank" rel="noopener"><img src="https://zotarellifilhoscientificworks.com/images/facebook-01.png" alt="Facebook" /></a> <a href="https://www.linkedin.com/company/zotarellifilhoscientificworks/" target="_blank" rel="noopener"><img src="https://zotarellifilhoscientificworks.com/images/linkedin-01.png" alt="LinkedIn" /></a></center></div> </div> </div> <div class="row"> <div class="col-lg-6"> <div class="journal-front-section-title">Journal indexed as follows</div> <br /><center> <p><strong>Database</strong></p> </center> <div class="row"> <div class="front-indexing col-md-3 col-lg-3"><a href="https://www.scopus.com/sourceid/21101192801" target="_blank" rel="noopener"><img src="https://zotarellifilhoscientificworks.com/images/scopus-1.jpg" alt="Scopus" width="430" height="126" border="0" /></a></div> <div class="front-indexing col-md-3 col-lg-3"><a href="https://scholar.google.com/citations?hl=en&view_op=search_venues&vq=international+journal+of+nutrology&btnG=" target="_blank" rel="noopener"><img src="https://zotarellifilhoscientificworks.com/images/google-scholar-1.jpg" alt="Google Scholar" width="430" height="126" border="0" /></a></div> <div class="front-indexing col-md-3 col-lg-3"><a href="https://app.dimensions.ai/discover/publication?search_mode=content&search_text=International%20Journal%20of%20Nutrology&search_type=kws&search_field=full_search" target="_blank" rel="noopener"><img src="https://zotarellifilhoscientificworks.com/images/dimensions-1.jpg" alt="Dimensions" width="430" height="126" border="0" /></a></div> </div> <div class="row"> <div class="front-indexing col-md-3 col-lg-3"><a href="https://oaji.net/journal-detail.html?number=11676" target="_blank" rel="noopener"><img src="https://zotarellifilhoscientificworks.com/images/oaij-1.jpg" alt="oaij" width="430" height="126" border="0" /></a></div> <div class="front-indexing col-md-3 col-lg-3"><a href="https://sdbindex.com/Sourceid/00000610" target="_blank" rel="noopener"><img src="https://zotarellifilhoscientificworks.com/images/scope-1.jpg" alt="scope" width="430" height="126" border="0" /></a></div> <div class="front-indexing col-md-3 col-lg-3"><a href="https://www.scinapse.io/journals/2764582022" target="_blank" rel="noopener"><img src="https://zotarellifilhoscientificworks.com/images/scinapse-1.jpg" alt="scinapse" width="430" height="126" border="0" /></a></div> </div> <div class="row"> <div class="front-indexing col-md-3 col-lg-3"><a href="https://europub.co.uk/journals/international-journal-of-nutrology-J-29230" target="_blank" rel="noopener"><img src="https://zotarellifilhoscientificworks.com/images/europub-1.jpg" alt="europub" width="430" height="126" border="0" /></a></div> <div class="front-indexing col-md-3 col-lg-3"><a href="https://www.scilit.net/journal/159" target="_blank" rel="noopener"><img src="https://zotarellifilhoscientificworks.com/images/scilit-1.jpg" alt="scilit" width="430" height="126" border="0" /></a></div> <div class="front-indexing col-md-3 col-lg-3"><a href="https://openalex.org/sources/S2764582022" target="_blank" rel="noopener"><img src="https://zotarellifilhoscientificworks.com/images/openalex-01.jpg" alt="Openalex" width="430" height="126" border="0" /></a></div> </div> <div class="row"> <div class="front-indexing col-md-3 col-lg-3"><a href="https://www.ascidatabase.com/publisher.php?v=2043" target="_blank" rel="noopener"><img src="https://zotarellifilhoscientificworks.com/images/asci-01.jpg" alt="Asian Science Citation Index" width="430" height="126" border="0" /></a></div> </div> <br /><center> <p><strong>Directories</strong></p> </center> <div class="row"> <div class="front-indexing col-md-3 col-lg-3"><a href="https://miguilim.ibict.br/handle/miguilim/7812" target="_blank" rel="noopener"><img src="https://zotarellifilhoscientificworks.com/images/miguilim-1.jpg" alt="miguilim" width="430" height="126" border="0" /></a></div> <div class="front-indexing col-md-3 col-lg-3"><a href="https://livre2.cnen.gov.br/ConsultaPorLetra.asp?Letra=I" target="_blank" rel="noopener"><img src="https://zotarellifilhoscientificworks.com/images/livre-1.jpg" alt="livre" width="430" height="126" border="0" /></a></div> <div class="front-indexing col-md-3 col-lg-3"><a href="https://diadorim.ibict.br/handle/1/3243" target="_blank" rel="noopener"><img src="https://zotarellifilhoscientificworks.com/images/diadorim-1.jpg" alt="diadorim" width="430" height="126" border="0" /></a></div> </div> <div class="row"> <div class="front-indexing col-md-3 col-lg-3"><a href="http://olddrji.lbp.world/JournalProfile.aspx?jid=2595-2854" target="_blank" rel="noopener"><img src="https://zotarellifilhoscientificworks.com/images/drji-1.jpg" alt="drji" width="430" height="126" border="0" /></a></div> <div class="front-indexing col-md-3 col-lg-3"><a href="https://www.latindex.org/latindex/ficha/24179" target="_blank" rel="noopener"><img src="https://zotarellifilhoscientificworks.com/images/latindex-1.jpg" alt="Directory of Research Journals Indexing" width="430" height="126" border="0" /></a></div> <div class="front-indexing col-md-3 col-lg-3"><a href="https://v2.sherpa.ac.uk/id/publication/39975" target="_blank" rel="noopener"><img src="https://zotarellifilhoscientificworks.com/images/sherpa-1.jpg" alt="jisc" width="430" height="126" border="0" /></a></div> </div> <div class="row"> <div class="front-indexing col-md-3 col-lg-3"><a href="https://portal.issn.org/resource/ISSN/2595-2854" target="_blank" rel="noopener"><img src="https://zotarellifilhoscientificworks.com/images/road-1.jpg" width="430" height="126" border="0" /></a></div> <div class="front-indexing col-md-3 col-lg-3"><a href="https://ezb.ur.de/searchres.phtml?bibid=UBK&colors=7&lang=en&jq_type1=QS&jq_term1=International+Journal+of+Nutrology" target="_blank" rel="noopener"><img src="https://zotarellifilhoscientificworks.com/images/ezb-1.jpg" alt="ezb" width="430" height="126" border="0" /></a></div> </div> <br /><center> <p><strong>Indexes and Portals</strong></p> </center> <div class="row"> <div class="front-indexing col-md-3 col-lg-3"><a href="https://www.semanticscholar.org/search?q=International%20Journal%20of%20Nutrology" target="_blank" rel="noopener"><img src="https://zotarellifilhoscientificworks.com/images/semantic-scholar-1.jpg" alt="Semantic Scholar" width="430" height="126" border="0" /></a></div> <div class="front-indexing col-md-3 col-lg-3"><a href="https://oasisbr.ibict.br/vufind/DataSources/Datasource?name=International%20Journal%20of%20Nutrology%20(Online)" target="_blank" rel="noopener"><img src="https://zotarellifilhoscientificworks.com/images/oasisbr-1.jpg" alt="oasisbr" width="430" height="126" border="0" /></a></div> <div class="front-indexing col-md-3 col-lg-3"><a href="https://isindexing.com/isi/journaldetails.php?id=15849" target="_blank" rel="noopener"><img src="https://zotarellifilhoscientificworks.com/images/isindexing-1.jpg" alt="isindexing" width="430" height="126" border="0" /></a></div> </div> <br /><center> <p><strong>Catalogs (Distributors)</strong></p> </center> <div class="row"> <div class="front-indexing col-md-3 col-lg-3"><a href="https://hollis.harvard.edu/primo-explore/search?query=issn,contains,2595-2854,AND&tab=everything&search_scope=everything&vid=HVD2&lang=en_US&mode=advanced&offset=0" target="_blank" rel="noopener"><img src="https://zotarellifilhoscientificworks.com/images/harvard-library-1.jpg" alt="harvard" width="430" height="126" border="0" /></a></div> <div class="front-indexing col-md-3 col-lg-3"><a href="https://www.worldcat.org/search?q=International+Journal+of+Nutrology&qt=owc_search" target="_blank" rel="noopener"><img src="https://zotarellifilhoscientificworks.com/images/worldcat-1.jpg" alt="worldcat" width="430" height="126" border="0" /></a></div> <div class="front-indexing col-md-3 col-lg-3"><a href="https://portal.issn.org/resource/ISSN/2595-2854" target="_blank" rel="noopener"><img src="https://zotarellifilhoscientificworks.com/images/issn-1.jpg" alt="issn" width="430" height="126" border="0" /></a></div> </div> <div class="row"> <div class="front-indexing col-md-3 col-lg-3"><a href="http://www.icmje.org/journals-following-the-icmje-recommendations/#I" target="_blank" rel="noopener"><img src="https://zotarellifilhoscientificworks.com/images/icmje-1.jpg" alt="icmje" width="430" height="126" border="0" /></a></div> <div class="front-indexing col-md-3 col-lg-3"><a href="https://nsdl.oercommons.org/courses/international-journal-of-nutrology" target="_blank" rel="noopener"><img src="https://zotarellifilhoscientificworks.com/images/nsdl-1.jpg" alt="nsdl" width="430" height="126" border="0" /></a></div> <div class="front-indexing col-md-3 col-lg-3"><a href="https://fatcat.wiki/container/cgzvzg7exna55ctxuxwkqq2b64" target="_blank" rel="noopener"><img src="https://zotarellifilhoscientificworks.com/images/fatcat-01.jpg" alt="fatcat" width="430" height="126" border="0" /></a></div> </div> <div class="row"> <div class="front-indexing col-md-3 col-lg-3"><a href="https://zdb-katalog.de/title.xhtml?idn=1163303224" target="_blank" rel="noopener"><img src="https://zotarellifilhoscientificworks.com/images/zdb-1.jpg" alt="ZDB" width="430" height="126" border="0" /></a></div> <div class="front-indexing col-md-3 col-lg-3"><a href="https://www.wikidata.org/wiki/Q96714315" target="_blank" rel="noopener"><img src="https://zotarellifilhoscientificworks.com/images/wikidata-1.jpg" alt="Wikidata" width="430" height="126" border="0" /></a></div> <div class="front-indexing col-md-3 col-lg-3"><a href="https://www.sudoc.fr/22929183X" target="_blank" rel="noopener"><img src="https://zotarellifilhoscientificworks.com/images/sudoc-1.jpg" alt="Sudoc" width="430" height="126" border="0" /></a></div> </div> </div> <div class="col-lg-3"> <div class="journal-front-section-title">Similarity check</div> <div class="row"><a href="https://www.ithenticate.com/" target="_blank" rel="noopener"><img class="center" src="https://zotarellifilhoscientificworks.com/images/ithenticate-1.jpg" alt="iThenticate" width="430" height="126" border="0" /></a></div> <div class="journal-front-section-title">Partners</div> <div class="row"><a href="https://www.abecbrasil.org.br/" target="_blank" rel="noopener"><img class="center" src="https://zotarellifilhoscientificworks.com/images/abec-1.jpg" alt="iThenticate" width="430" height="126" border="0" /></a></div> <div class="row"><a href="https://www.cpmsl.lk/" target="_blank" rel="noopener"><img class="center" src="https://zotarellifilhoscientificworks.com/images/cpmsl-2.jpg" alt="College of Palliative Medicine of Sri Lanka" width="430" height="126" border="0" /></a></div> <div class="row"><a href="https://orcid.org/0000-0003-4328-1829" target="_blank" rel="noopener"><img class="center" src="https://zotarellifilhoscientificworks.com/images/orcid-1.jpg" alt="ORCID" width="430" height="126" border="0" /></a></div> <div class="row"><a href="https://search.crossref.org/?q=International+Journal+of+Nutrology&from_ui=yes" target="_blank" rel="noopener"><img class="center" src="https://zotarellifilhoscientificworks.com/images/crossref-1.jpg" alt="Crossref" width="430" height="126" border="0" /></a></div> <div class="row"><a href="https://www.finut.org/" target="_blank" rel="noopener"><img class="center" src="https://zotarellifilhoscientificworks.com/images/finut-1.jpg" alt="Crossref" width="430" height="126" border="0" /></a></div> <div class="row"><a href="https://www.ibilce.unesp.br/#!/pos-graduacao/programas-de-pos-graduacao/engenharia-e-ciencia-de-alimentos/apresentacao/corpo-docente/" target="_blank" rel="noopener"><img class="center" src="https://zotarellifilhoscientificworks.com/images/unesp-1.jpg" alt="Unesp" width="430" height="126" border="0" /></a></div> <div class="row"><a href="https://sph.uth.edu/research/centers/cchi/" target="_blank" rel="noopener"><img class="center" src="https://zotarellifilhoscientificworks.com/images/uthealth-1.jpg" alt="Uthealth" width="430" height="126" border="0" /></a></div> <div class="row"><a href="https://www.obesity.org/" target="_blank" rel="noopener"><img class="center" src="https://zotarellifilhoscientificworks.com/images/obs-1.jpg" alt="OBS" width="430" height="126" border="0" /></a></div> <div class="row"><a href="https://felanpe.org/" target="_blank" rel="noopener"><img class="center" src="https://zotarellifilhoscientificworks.com/images/felanpe-1.jpg" alt="Felanpe" width="430" height="126" border="0" /></a></div> </div> <div class="col-lg-3"> <div class="journal-front-section-title">Archived In</div> <center> <img src="https://mednext.zotarellifilhoscientificworks.com/public/site/images/metasciencepresssupport3/issn.png" alt="" width="231" height="127" /></center><center><img src="https://mednext.zotarellifilhoscientificworks.com/public/site/images/metasciencepresssupport3/pkp.png" alt="" width="382" height="102" /></center></div> </div> </div>en-US<p><strong>Licenses, Copyright & Permissions</strong><br /><strong>1. Transfer of copyright:</strong><br />The corresponding author or designee below, with the consent of all co-authors, hereby transfers to the publishers and copyright ownership in the referenced submitted work, including all versions in any format now known or hereafter developed and sell the articles worldwide in all languages and media (Publishing Agreement & Copyright Transfer Form).</p> <p><br /><strong>2. Rights and obligations of Publisher:</strong><br />The Publisher's rights to the Article shall especially include, but shall not be limited to:<br />Ability to publish an electronic version of the Article via the website of the publisher or any other electronic format or means of electronic distribution provided by or through publisher from time to time, selling the Article world-wide (through subscriptions, Pay-per-View, single archive sale, etc.)<br />Transforming to and selling the Article through any electronic format Publishing the Article in the printed Journals as listed on the official Website of Publisher<br />Transferring the copyright and the right of use of the Article on to any third party Translating the Article in any language Taking measures on behalf of the Author against in fringement, in appropriate use of the Article, libel or plagiarism.<br />Publishers agrees to send the text of the manuscript to the corresponding author e-mail address of Author indicated in the present Statement for preview before the first publishing either in paper and/or electronic format (Proof). Author should return the corrected test of the manuscript within 5 days to the publisher. Author shall, however, not make any change to the content of the Article during the First Proof preview.</p> <p><strong>3. Rights and obligations of Author:</strong><br />The Author declares and warrants that he/she is the exclusive author of the Article– or has the right to represent all co-authors of the Article and has not granted any exclusive or non-exclusive right to the Article to any third party prior to the execution of the present Statement and has the right therefore to enter in to the present Statement and entitle the Publisher the use of the Article subject to the present Statement. By executing the present Statement Author confirms that the Article is free of plagiarism, and that Author has exercised reasonable care to ensure that it is accurate and, to the best of Author's knowledge, does not contain any thing which is libellous, or obscene, or infringes on anyone's copyright, right of privacy, or other rights. The Author expressively acknowledges and accepts that he/she shall been titled to no royalty (or any other fee) related to any use of the Article subject to the present Statement. The Author further accepts that he/she will not been titled to dispose of the copyright of the final, published version of the Article or make use of this version of the Article in any manner after the execution of the present Statement. The Author is entitled, however, to self-archive the preprint version of his/her manuscript. The preprint version is the<br />Author's manuscript or the galley proof or the Author's manuscript along with the corrections made in the course of the peer-review process.<br />The Author's right to self-archive is irrespective of the format of the preprint (.doc, .tex., .pdf) version and self-archiving includes the free circulation of this file via e-mail or publication of this pre print on the Author's web page or on the Author's institution a repository with open or<br />restricted access. When self-archiving a paper the Author should clearly declare that the archived file is not the final published version of the paper, he/she should quote the correct citation and enclose a link to the published paper( http://dx.doi.org/[DOI of the Article without brackets]).<br />4. Use of third party content as part of the Article When not indicating any co-authors in the present Statement Author confirms that he/she is the exclusive author of the Article. When indicating co- authors in the present Statement Author declares and warrants that all co-authors have been listed and Author has the exclusive and<br />unlimited right to represent all the co-authors of the Article and to enter into the present Statement on their behalf and as a consequence all declarations made by Author in the present Statement are made in the name of the co-authors as well. Author also confirms that he/she shall hold Publisher harmless of all third-party claims in connection to non-authorized use of the Article by Publisher. Should Author wish to reuse material sourced from third parties such as other copyright holders, publishers, authors, etc. as part of the Article, Author bears responsibility for acquiring and clearing of the third party permissions for such use before submitting the Article to the Publisher for acceptance. Author shall<br />hold Publisher harmless from all third party claims in connection to the unauthorized use of any material under legal protection forming a part of the Article.</p> <p><strong>5.Share with Colleagues:</strong><br />Subject to the publishers, Authors may send or otherwise transmit electronic files of the Submitted or Accepted Work to interested colleagues<br />prior to, or after, publication. Sharing of the Published Work with colleagues is permitted if it is done via the journal articles on Request authordirected link. The sharing of any version of the Work with colleagues is only permitted if it is done for non-commercial purposes; that no fee is charged; and that it is not done on a systematic basis, e.g. mass emailings, posting on a listserv, etc. Recipients should be informed that further redistribution of any version of the Work is not allowed. Authorized users of the publisher's website may also email a link to the Author's article directly to colleagues as well as recommend and share a link to the Author's article with known colleagues through popular social networking services such as Facebook, Twitter, or CiteULike.</p> <p><strong>6. Retained Rights:</strong><br />The Author(s) retain copyright and all other intellectual property rights.<br />Article Processing Fees International Journal of Nutrology (IJN) is an open access journal. Articles in the journal are free to access, download, share, and reuse.<br />Also, we do not charge any submission charges from the authors.<br />Open Access Statement<br />Creative Commons Licenses<br />International Journal of Nutrology (IJN) articles are published open access under a CC BY license (Creative Commons Attribution 4.0 International License). The CC BY license allows for maximum dissemination and re-use of open access materials and is preferred by many<br />research funding bodies. Under this license users are free to share (copy, distribute and transmit) and remix (adapt) the contribution including for commercial purposes, providing they attribute the contribution in the manner specified by the author or licensor (read full legal code).<br />Under Creative Commons, authors retain copyright in their articles.<br />Visit our open research site for more information about Creative Commons licensing.</p>[email protected] (ABRAN - Brazilian Association of Nutrology)[email protected] (MetaScience Press - IT Services)Fri, 20 Dec 2024 17:35:42 +0000OJS 3.3.0.8http://blogs.law.harvard.edu/tech/rss60Major clinical studies on the relationship between testosterone levels and aging in men: a systematic review
https://ijn.zotarellifilhoscientificworks.com/index.php/ijn/article/view/408
<p><strong>Introduction:</strong> After 30 years of age, testosterone levels decline at a rate of 1-2% per year, which correlates with an increased incidence of late-onset hypogonadism diagnosed in middle-aged and elderly men. Testosterone replacement therapy (TRT) is emerging as a promising solution for aging-related problems. <strong>Objective: </strong>This study aimed to present the main clinical studies on the relationship between testosterone levels and aging in men, as well as an analysis of the reduction in physical and metabolic comorbidities. <strong>Methods:</strong> The systematic review rules of the PRISMA Platform were followed. The search was conducted from August to September 2024 in the Scopus, PubMed, Science Direct, Scielo, and Google Scholar databases. The quality of the studies was based on the GRADE instrument, and the risk of bias was analyzed according to the Cochrane instrument. <strong>Results and Conclusion:</strong> A total of 86 articles were found. A total of 23 articles were fully evaluated, and 11 were included and developed in the present systematic review study. Considering the Cochrane tool for risk of bias, the overall assessment resulted in 23 studies with a high risk of bias and 21 studies that did not meet GRADE and AMSTAR-2. Most studies showed homogeneity in their results, with X<sup>2</sup>=77.4%>50%. It was concluded that in the setting of aging in men, late-onset hypogonadism is the clinical entity characterized by low testosterone concentrations associated with clinical symptoms in the absence of organic disease in elderly men. It has been associated with metabolic syndrome, reduced bone mineral density, and increased risk of cardiovascular morbidity and mortality. Although testosterone replacement therapy reverses most of these conditions in young hypogonadal men, the risk/benefit ratio of testosterone replacement therapy in older men is debatable. In middle-aged and older men with hypogonadism and low libido, testosterone replacement therapy for 2 years improved sexual activity, hypogonadal symptoms, and sexual desire, but not erectile function. Furthermore, men with low testosterone, elevated luteinizing hormone, or deficient estradiol concentrations had increased all-cause mortality. Testosterone treatment aimed at achieving physiological concentrations in middle-aged and older men may improve lean body mass, while exercise training improves lean body mass, aerobic fitness, and strength.</p>Jeffeson Alexandre Azevedo de Araujo, Kennya Medeiros Lopes de Barros Lima, Ana Gabriela de Magalhães, Laís Martins Borges, Karlla Gabrielly Claudino Santos, Leonardo Honório de Andrade Mélo Neto, Vitor Bezerra de Medeiros, Hugo Menezes Lopes, Diego Pereira Netto, Brysa Freitas Dall’orto, Nicole Velasco Campos
Copyright (c) 2024 Jeffeson Alexandre Azevedo de Araujo, Kennya Medeiros Lopes de Barros Lima, Ana Gabriela de Magalhães, Laís Martins Borges, Karlla Gabrielly Claudino Santos, Leonardo Honório de Andrade Mélo Neto, Vitor Bezerra de Medeiros, Hugo Menezes Lopes, Diego Pereira Netto, Brysa Freitas Dall’orto, Nicole Velasco Campos
https://creativecommons.org/licenses/by/4.0
https://ijn.zotarellifilhoscientificworks.com/index.php/ijn/article/view/408Wed, 12 Feb 2025 00:00:00 +0000Metabolic significance of nutritional treatment before and after bariatric surgery: a systematic review
https://ijn.zotarellifilhoscientificworks.com/index.php/ijn/article/view/407
<p><strong>Introduction:</strong> According to the American Society for Metabolic and Bariatric Surgery (ASMBS), the rate of bariatric surgery (BS) increased from 158 thousand in 2011 to 196 thousand in 2015. Lifestyle modifications, such as healthy eating and correct physical activity programs, can improve surgical results. Thus, the most important aspect in the medical management of bariatric patients refers to nutritional management. <strong>Objective:</strong> It was to carry out a systematic review to list the main approaches and significance of nutritional treatment before and after bariatric surgery, to mitigate the metabolic damage caused by nutrient deficits. <strong>Methods:</strong> The PRISMA Platform systematic review rules were followed. The search was carried out from August to October 2024 in the Web of Science, Scopus, PubMed, Science Direct, Scielo, and Google Scholar databases. The quality of the studies was based on the GRADE instrument and the risk of bias was analyzed according to the Cochrane instrument. <strong>Results and Conclusion:</strong> 127 articles were found. A total of 45 articles were evaluated in full and 30 were included and developed in the present systematic review study. Considering the Cochrane tool for risk of bias, the overall assessment resulted in 25 studies with a high risk of bias and 27 studies that did not meet GRADE and AMSTAR-2. Most studies showed homogeneity in their results, with X<sup>2</sup>=62.5%>50%. It was concluded that the most important aspects of the medical management of bariatric patients refer to nutritional management. Before bariatric surgery, nutritional status should be checked and preoperative weight loss may be attempted. Very low-calorie diets and very low-calorie ketogenic diets are often prescribed in the last few months before surgery. It was observed that the recommendations were gathered to assist in individualized clinical practice in the nutritional management of patients with obesity, including nutritional management. Iron status can be affected by inflammation of adipose tissue and increased expression of the systemic iron-regulating protein hepcidin. The postoperative recommendation for vitamin B12 (cobalamin) should be 350-500 micrograms/1000 micrograms monthly, and postoperative folate (folic acid) should be 1,000 micrograms per day.</p>Renata Cristina Taveira Azevedo, Thuany da Silva Teixeira, Alessandra Leal de Oliveira, Mariana Carolina Braga, Lucas Emanuel de Lima Azevedo, Lara Souza Crepaldi, Nathalia Galindo Cordeiro, Rodrigo Siqueira de Carvalho
Copyright (c) 2025 Renata Cristina Taveira Azevedo, Thuany da Silva Teixeira, Alessandra Leal de Oliveira, Mariana Carolina Braga, Lucas Emanuel de Lima Azevedo, Lara Souza Crepaldi, Nathalia Galindo Cordeiro, Rodrigo Siqueira de Carvalho
https://creativecommons.org/licenses/by/4.0
https://ijn.zotarellifilhoscientificworks.com/index.php/ijn/article/view/407Mon, 03 Feb 2025 00:00:00 +0000Exploring the Relationship Between Fatigue Severity and Clinical Parameters in Hemodialysis Patients Utilizing FACIT-F Scale: A Cross-sectional Study in West Bank Hospitals
https://ijn.zotarellifilhoscientificworks.com/index.php/ijn/article/view/406
<p>Fatigue is one of the most common symptoms experienced by patients with End-Stage Renal Disease (ESRD) and it can be defined as weakness, exhaustion, incapacitating, and disorder. The purpose of this cross-sectional study is to determine the correlation between fatigue severity and key clinical parameters in hemodialysis patients in West Bank hospitals. 62 adult dialysis patients were evaluated for fatigue severity using the Functional Assessment of Chronic Illness Therapy - Fatigue Scale (FACIT-F). Demographic information, health behaviors, and clinical characteristics were gathered. The findings demonstrated a strong negative association between fatigue severity and hemoglobin levels (r=-0.319, p=0.023), emphasizing the role of low hemoglobin levels in increasing fatigue. There were no significant relationships between weariness and serum creatinine, phosphorus, or calcium levels. These findings emphasize the necessity of monitoring and treating hemoglobin levels in dialysis patients' tiredness management, pointing to further research and viable therapies.</p>Abdalla Qawasmeh, Issa Salha, Khadija Mohammad, Mohammad Farid Al Tamimi, Nizar Abu Hamdeh, Marah Qassrawi, Duha Najajra, Abdulrahman Abu-Haltam, Mohammad Alnees
Copyright (c) 2024 Abdalla Qawasmeh, Issa Salha, Khadija Mohammad, Mohammad Farid Al Tamimi, Nizar Abu Hamdeh, Marah Qassrawi, Duha Najajra, Abdulrahman Abu-Haltam, Mohammad Alnees
https://creativecommons.org/licenses/by/4.0
https://ijn.zotarellifilhoscientificworks.com/index.php/ijn/article/view/406Thu, 30 Jan 2025 00:00:00 +0000Impacts of obesity and comorbidities on sexual dysfunction in men and women: a systematic review
https://ijn.zotarellifilhoscientificworks.com/index.php/ijn/article/view/405
<p><strong>Introduction:</strong> Obesity, with more than 2.0 billion people worldwide, is associated with numerous comorbidities, affecting male and female sexual and reproductive function. <strong>Objective:</strong> This study explored the main clinical studies on the impacts of obesity on sexual dysfunction in men and women, as well as treatment proposals in an attempt to mitigate or resolve this condition. <strong>Methods:</strong> The systematic review rules of the PRISMA Platform were followed. The search was carried out from September to October 2024 in the Web of Science, Scopus, PubMed, Science Direct, Scielo, and Google Scholar databases. The quality of the studies was based on the GRADE instrument and the risk of bias was analyzed according to the Cochrane instrument. <strong>Results and Conclusion: </strong>A total of 95 articles were found. A total of 30 articles were evaluated in full and 14 were included and developed in the present systematic review study. Considering the Cochrane tool for risk of bias, the overall assessment resulted in 23 studies with high risk of bias and 25 studies that did not meet GRADE and AMSTAR-2. Most studies showed homogeneity in their results, with X<sup>2</sup>=72.5%>50%. It was concluded that obesity is associated with substantial and significant impairments in quality of life. Weight loss has been shown to improve sexual function in men and women with obesity. The impact of weight loss medications and the long-term effect of bariatric surgery on sexual function require further studies. Higher visceral adiposity index is independently related to the risk of erectile dysfunction and that early intervention is necessary to reduce the progression of erectile dysfunction with high levels of visceral adiposity index. It was shown that BMI, age, smoking, diabetes and hypertension were associated with higher odds of reporting decreased sexual function.</p>Deangelo Cláudio Gomes de Lima, Rafael Tinoco Alves, Jose Manuel Torres Garcia, Iuri Sanzio Souto, Karlla Vieira Campos Ricatto, Luciene Pereira de Oliveira, Renatto Souza Nunes Cabral, Celso Alexandre Alves, Natashira Soares Torres, Jussara Santos Sousa
Copyright (c) 2025 Deangelo Cláudio Gomes de Lima, Rafael Tinoco Alves, Jose Manuel Torres Garcia, Iuri Sanzio Souto, Karlla Vieira Campos Ricatto, Luciene Pereira de Oliveira, Renatto Souza Nunes Cabral, Celso Alexandre Alves, Natashira Soares Torres, Jussara Santos Sousa
https://creativecommons.org/licenses/by/4.0
https://ijn.zotarellifilhoscientificworks.com/index.php/ijn/article/view/405Thu, 30 Jan 2025 00:00:00 +0000Action of probiotics and nutrients in the management of tregs cells in patients with obesity and cancer: a systematic review
https://ijn.zotarellifilhoscientificworks.com/index.php/ijn/article/view/404
<p><strong>Introduction:</strong> In the context of immunomodulation in patients with obesity and cancer, Bifidobacterium is one of the most commonly used probiotics and activates the anti-CTLA-4 antibody, a checkpoint inhibitor that frequently causes autoimmunity in humans undergoing cancer treatment. Immunotherapy enhances the host's immune system to produce antitumor effects, primarily by stimulating Treg cells. <strong>Objective:</strong> It was to highlight how probiotics and nutrients can stimulate regulatory T cells in patients with obesity and cancer, to immunomodulate and treat these patients. <strong>Methods:</strong> The PRISMA Platform systematic review rules were followed. The search was carried out from April to June 2024 in the Scopus, PubMed, Science Direct, Scielo, and Google Scholar databases. The quality of the studies was based on the GRADE instrument and the risk of bias was analyzed according to the Cochrane instrument. <strong>Results and Conclusion:</strong> A total of 137 articles were found, and 39 articles were evaluated in full, and 31 were included and developed in the present systematic review study. Considering the Cochrane tool for risk of bias, the overall assessment resulted in 27 studies with a high risk of bias and 25 studies that did not meet GRADE and AMSTAR-2. Most studies showed homogeneity in their results, with X<sup>2</sup>=68.9%>50%. It was concluded that oral administration of butyrate, propionate, and acetate, individually or in combination, led to an increase in the number of Treg cells in the colon. Also, all-trans retinoic acid (atRA), a bioactive form of vitamin A stimulates Treg cells in the human intestine. Probiotics, together with gut microbiota, have been increasingly proposed to improve immune checkpoint blockade treatments against cancer by activating Treg cells.</p>Rafael Tinoco Alves, Deangelo Cláudio Gomes de Lima, Jose Manuel Torres Garcia, Iuri Sanzio Souto, Karlla Vieira Campos Ricatto, Luciene Pereira de Oliveira, Renatto Souza Nunes Cabral, Celso Alexandre Alves, Natashira Soares Torres, Jussara Santos Sousa
Copyright (c) 2024 Rafael Tinoco Alves, Deangelo Cláudio Gomes de Lima, Jose Manuel Torres Garcia, Iuri Sanzio Souto, Karlla Vieira Campos Ricatto, Luciene Pereira de Oliveira, Renatto Souza Nunes Cabral, Celso Alexandre Alves, Natashira Soares Torres, Jussara Santos Sousa
https://creativecommons.org/licenses/by/4.0
https://ijn.zotarellifilhoscientificworks.com/index.php/ijn/article/view/404Thu, 30 Jan 2025 00:00:00 +0000Importance of nutrological management and gut microbiota in alzheimer's disease: a systematic review
https://ijn.zotarellifilhoscientificworks.com/index.php/ijn/article/view/403
<p><strong>Introduction:</strong> In the context of neurodegenerative diseases, Alzheimer's disease (AD) is the most common form of dementia. It is estimated that more than 46 million people are affected worldwide. Several factors contribute to the risk of developing late-onset Alzheimer's disease, including advanced age, genetic factors, family history, history of head trauma, hypertension in midlife, obesity, diabetes, and hypercholesterolemia. Studies have shown the important role of the gut microbiota in controlling this condition, together with adequate nutrition. <strong>Objective:</strong> It was to analyze the relationship between dietary patterns, gut microbiota, micro and macronutrients, and cognitive disorders in Alzheimer's disease. <strong>Methods:</strong> The systematic review rules of the PRISMA Platform were followed. The search was conducted from May to August 2024 in the Scopus, PubMed, Science Direct, Scielo, and Google Scholar databases. The quality of the studies was based on the GRADE instrument and the risk of bias was analyzed according to the Cochrane instrument. <strong>Results and Conclusion:</strong> A total of 140 articles were found. 75 articles were fully assessed and 30 were included and developed in the present systematic review study. Considering the Cochrane tool for risk of bias, the overall assessment resulted in 15 studies with a high risk of bias and 25 studies that did not meet GRADE and AMSTAR-2. Most studies showed homogeneity in their results, with X<sup>2</sup>=89.5%>50%. It was concluded that several antioxidants found in a healthy natural diet can efficiently attenuate free radical attacks and neutralize dysregulated pro-oxidants, reducing oxidative stress and the induction of degenerative diseases such as Alzheimer's disease. Studies have found that plasma lipopolysaccharide levels in patients with Alzheimer's disease were three times higher than in healthy controls. Thus, increased concentrations of plasma lipopolysaccharide and fecal calprotectin indicate an altered intestinal barrier function and increased inflammation and intestinal permeability in patients with Alzheimer's disease.</p>Márcia Cavalheiro Alves, Mateus Antunes Nogueira, Hugo Menezes Lopes, Ricardo de Oliveira Carvalho, Ana Claudia Santana Cano, Vittor Cândido Soares, Frederico Teixeira Izidorio, Juliana da Silva Pereira, Marília de Andrade Salvá, Thamyres Veras Alves
Copyright (c) 2024 Márcia Cavalheiro Alves, Mateus Antunes Nogueira, Hugo Menezes Lopes, Ricardo de Oliveira Carvalho, Ana Claudia Santana Cano, Vittor Cândido Soares, Frederico Teixeira Izidorio, Juliana da Silva Pereira, Marília de Andrade Salvá, Thamyres Veras Alves
https://creativecommons.org/licenses/by/4.0
https://ijn.zotarellifilhoscientificworks.com/index.php/ijn/article/view/403Fri, 24 Jan 2025 00:00:00 +0000Clinical evidence on nutrological management and gut microbiota in inflammatory bowel diseases: a systematic review
https://ijn.zotarellifilhoscientificworks.com/index.php/ijn/article/view/402
<p><strong>Introduction:</strong> The main risk factor for inflammatory bowel disease (IBD) is a positive family history. Crohn's disease (CD) can affect individuals aged 15 to 40 and 50 to 80 years, with a higher percentage in women. Ulcerative colitis (UC) can start at any age. Metabolism encompasses the interactions between diet, the microbiome, and cellular enzymatic processes that generate the chemical pathways necessary to sustain life. Endogenous metabolites and dietary nutrients can directly influence epigenetic enzymes. Epigenetic modifications to DNA and histone proteins alter cell fate by controlling chromatin accessibility and downstream gene expression patterns. <strong>Objective:</strong> It was to highlight the main interactions between nutrition and gut microbiota in the treatment of inflammatory bowel diseases. <strong>Methods:</strong> The present study followed the international systematic review model (PRISMA). This study was carried out from July to September 2024. It included randomized controlled, prospective, and retrospective studies published from 2013 to 2023. The Cohen test was performed to calculate the Effect Size and the inverse error standard (precision or sample size) for the risk of bias (Funnel Plot). <strong>Results and Conclusion:</strong> A total of 30 articles were found, and 17 clinical studies on the modulation of diet to control IBD were included in this study. These studies have shown reductions in persistent gut symptoms, improved gut microbiota, reduced markers of inflammation, and improved quality of life. Diet has an important role in controlling and even remitting IBD. The studies were homogeneous in results, with X<sup>2</sup> = 82.5%, which increases the reliability of clinical results on the importance of diet in modulating IBD.</p>Cristiane Reis e Lopes Telles, Maria Aparecida Orlando de Moraes Ferreira, Priscila Mendes Maia Rocha, Luciene Pereira de Oliveira, Gabriela Ricardi, Katia Alves Ramos, Antônio Carlos da Silva Junior, Ariadne Fonseca Carvalho Silva, Thaysa Andressa Brandão Vilela Teixeira, Eduardo Vinicius França Moreira
Copyright (c) 2025 Cristiane Reis e Lopes Telles, Maria Aparecida Orlando de Moraes Ferreira, Priscila Mendes Maia Rocha, Luciene Pereira de Oliveira, Gabriela Ricardi, Katia Alves Ramos, Antônio Carlos da Silva Junior, Ariadne Fonseca Carvalho Silva, Thaysa Andressa Brandão Vilela Teixeira, Eduardo Vinicius França Moreira
https://creativecommons.org/licenses/by/4.0
https://ijn.zotarellifilhoscientificworks.com/index.php/ijn/article/view/402Fri, 24 Jan 2025 00:00:00 +0000Recommendations and guidance on Cobalamin (Vitamin B12) based on the Delphi method
https://ijn.zotarellifilhoscientificworks.com/index.php/ijn/article/view/401
<p><strong>Introduction:</strong> Vitamins are essential micronutrients for the body to function. Cobalamins (Cbls) are watersoluble compounds, acting as cofactors in enzymatic reactions. However, the use of Cbls in the clinical environment is still controversial. <strong>Objective:</strong> It was to discuss the topic and help guide different professionals, experts were brought together to discuss criteria concerning the diagnosis, indications, and use of cobalamin. <strong>Methods: </strong>The study was carried out using the Delphi method. Topics were initially created to direct the discussion and initial contributions. In the first meeting with the panelists, questions were formulated. The questions were distributed to all panelists. With the contributions, a text with the answers was created, and a third round to review the contributions and agree with the text was carried out.<strong> Results: </strong>The main topics related to the use of cobalamin were identified. <strong>Conclusion: </strong>The main topics related to this topic include risk groups of deficiency of ingestion or absorption by the gastrointestinal tract. The deficiency diagnosis must be made through laboratory tests, and early indication must be made when a significant cobalamin deficiency is identified, to avoid irreversible clinical conditions. A recommended practice is monitoring between 2 and 6 months after starting cobalamin replacement. Evidence Level:6.</p>Tiago Lazzaretti Fernandes, Dayse Maria Lourenço, Durval Ribas Filho, Glaucia Carneiro, Gustavo Loureiro, João Toniolo Neto, Luiz Claudio Cameron, Sonia Maria Dozzi Brucki, Nairo Massakazu Sumita, Henry Dan Kiyomoto, André Pedrinelli
Copyright (c) 2024 Tiago Lazzaretti Fernandes, Dayse Maria Lourenço, Durval Ribas Filho, Glaucia Carneiro, Gustavo Loureiro, João Toniolo Neto, Luis Claudio Cameron, Sonia Maria Dozzi Brucki, Nairo Massakazu Sumita, Henry Dan Kiyomoto, André Pedrinelli
https://creativecommons.org/licenses/by/4.0
https://ijn.zotarellifilhoscientificworks.com/index.php/ijn/article/view/401Mon, 13 Jan 2025 00:00:00 +0000Major clinical outcomes of the action of the co-agonist tirzepatide to liraglutide and semaglutide in the treatment of obesity and type 2 diabetes mellitus: a systematic review
https://ijn.zotarellifilhoscientificworks.com/index.php/ijn/article/view/400
<p><strong>Introduction:</strong> Obesity is a chronic disease that affects a significant portion of the population. In Brazil, in surveillance research on risk and protective factors for diseases, more than half of the Brazilian population, 56% are overweight. In this scenario, liraglutide and semaglutide are medication for the treatment of type 2 diabetes mellitus (T2DM) and obesity. Tirzepatide is the first dual GLP1/GIP receptor co-agonist that has been approved for the treatment of T2DM and obesity. <strong>Objective: </strong>It was to present the major clinical outcomes of the action of the co-agonist tirzepatide to liraglutide and semaglutide in the treatment of obesity and type 2 diabetes mellitus. <strong>Methods:</strong> The PRISMA Platform systematic review rules were followed. The research was carried out from September to October 2024 in the Scopus, PubMed, Science Direct, Scielo, and Google Scholar databases. The quality of the studies was based on the GRADE instrument and the risk of bias was analyzed according to the Cochrane instrument. <strong>Results and Conclusion:</strong> A total of 84 articles were found, and 52 articles were evaluated and 23 were included in this systematic review. Considering the Cochrane tool for risk of bias, the overall assessment resulted in 8 studies with a high risk of bias and 19 studies that did not meet GRADE. Most studies showed homogeneity in their results, with X<sup>2</sup> =79.8% >50%. It was concluded that in people without diabetes, 5 to 15 mg of tirzepatide once weekly for the treatment of obesity (SURMOUNT-1) resulted in substantial reductions in body weight (16.5% to 22.4%) over some time. 72 weeks. Furthermore, liraglutide (3.0 mg) as a medication for the treatment of obesity, in association with lifestyle changes, in patients with and without diabetes proved to be a good therapeutic option with a response about weight loss and maintenance, in addition to benefits secondary to clinical comorbidities associated with obesity.</p>Helena Ramalho Arvate
Copyright (c) 2024 Helena Ramalho Arvate
https://creativecommons.org/licenses/by/4.0
https://ijn.zotarellifilhoscientificworks.com/index.php/ijn/article/view/400Wed, 08 Jan 2025 00:00:00 +0000Analysis of the frequency of consumption of dairy foods as a source of calcium in women in the age group of 19 to 30 years: a prospective observational and cross-sectional study
https://ijn.zotarellifilhoscientificworks.com/index.php/ijn/article/view/399
<p>Throughout a woman's life, the amount of calcium needed by her body changes, and in adulthood, this value is relatively lower than in adolescence and post-menopause. Even so, considering that bones are stores of calcium, consumption of the nutrient in adulthood is essential to avoid future problems such as osteoporosis and osteopenia. The objective of this study was to assess the frequency of consumption of dairy products rich in calcium, by adult women between 19 and 30 years old in the city of Catanduva, Brazil. A descriptive cross-sectional observational study was carried out with 114 volunteers. The frequency of consumption of milk and dairy products in the last 12 months was measured through an anonymous questionnaire via “google forms”. It was found that among the most consumed dairy foods are cheese, but most calcium-rich foods are never eaten by the women in the study. The low calcium intake can be explained by the increase in the financial cost of dairy products on the market and by the presence of women who are lactose intolerant. Therefore, the consumption of dairy foods must be encouraged among women, while alternatives must be thought of so that the consumption of calcium, of medicinal importance, is not affected by the prices of dairy products on the market or by the presence or absence of diseases related to lactose.</p>Ana Beatriz Quinzani Baptista, Guilherme Murari Mario, Isabela Fernanda da Silva, Julia Tricta Cano, Leticia Ricci Magrini, Gabrielle Sadano Veiga dos Santos, Amanda Alves Freitas, Sofia Beckers Marques de Almeida, Tainara Costa Singh, Durval Ribas Filho
Copyright (c) 2024 Ana Beatriz Quinzani Baptista, Guilherme Murari Mario, Isabela Fernanda da Silva, Julia Tricta Cano, Leticia Ricci Magrini, Tainara Costa Singh, Durval Ribas Filho
https://creativecommons.org/licenses/by/4.0
https://ijn.zotarellifilhoscientificworks.com/index.php/ijn/article/view/399Thu, 02 Jan 2025 00:00:00 +0000Assessment of the knowledge on nutrology among medical course students: an observational cross-sectional study
https://ijn.zotarellifilhoscientificworks.com/index.php/ijn/article/view/397
<p><strong>Introduction:</strong> An unbalanced diet is responsible for more deaths than any other risk factor, including smoking. By definition, Nutrology is the medical specialty whose function is to prevent, diagnose and treat nutroneurometabolic diseases. As it is a relatively new specialty, it has not yet become part of the basic curriculum as a mandatory subject in most medical schools. This fact means that students have little or no contact with the specialty during their academic training. <strong>Objective:</strong> The objective of this study was to evaluate the knowledge on Nutrology among medical students. <strong>Methods:</strong> An observational and cross-sectional study was conducted to assess the knowledge of students enrolled in the Ugraft Journey of the Plastic Surgery Leagues of Rio Grande do Sul. Data collection took place through the application of an online questionnaire comprising 14 questions<strong>. Results:</strong> A total of 170 participants spanning across all semesters of the course, representing 7 universities (UFSM, UFCSPA, UFN, UFAL, Unoeste, Univates, and Unijuí). The participants were aged between 18 and 43 years old, 114 were female and 56 were male. In regard to the question of which course Nutrology is a part of, 84.1% answered Medicine, 14.7% answered Nutrition, and 1.2% answered another course. Additionally, 67.6% stated that they do not know or are not sure about the area of activity of Nutrology, while only 17.6% have already consulted a Nutrologist. Concerning the significance of dietary guidance and supplementation during the pre- and post-operative phases of surgery, 98.2% deemed it advantageous for the patient. When it came to distinguishing between the various indications for oral dietary supplementation, enteral, or parenteral therapy, 74.7% did not know how to differentiate them. Regarding the safety of prescribing a food supplement, 90% do not feel able to do so. As for the meaning of the acronym MNTT, 93% are unaware. Regarding obesity being a chronic disease, 92.4% agreed. Regarding the desire to undertake a residency in Nutrology, 12.9% expressed interest. Finally, regarding the importance of the subject of Nutrology in the curriculum, 94% considered it important. <strong>Conclusion:</strong> Despite the increasing prevalence of nutrition-related diseases and the evidence showing that poor diet is responsible for more deaths than any other risk factor, studies have observed that the majority of medical students feel unprepared regarding the subject. The findings of this study could serve as motivation for institutions to reconsider the significance of incorporating the discipline of Nutrology into the medical curriculum.</p>Paloma Salomone, Maurício Schneider Viaro, Michely Machado, Silvana Leão, Liliane Alves Pereira
Copyright (c) 2024 Paloma Salomone, Maurício Schneider Viaro, Michely Machado, Silvana Leão, Liliane Alves Pereira
https://creativecommons.org/licenses/by/4.0
https://ijn.zotarellifilhoscientificworks.com/index.php/ijn/article/view/397Mon, 18 Nov 2024 00:00:00 +0000Adequate nutrological treatment for patients with chronic kidney disease: a systematic review
https://ijn.zotarellifilhoscientificworks.com/index.php/ijn/article/view/396
<p><strong>Introduction:</strong> In the scenario of chronic kidney disease (CKD), data from the World Health Organization show that CKD affects approximately 10% of the world population, particularly in low- and middle-income countries. In the USA alone, approximately 37 million adults are affected, given that diagnosis is late due to the lack of apparent symptoms in the early stages. Due to limited access to diagnosis and treatment, CKD has become the 12th leading cause of death in the world, making adequate nutritional therapy necessary as the main treatment.<strong> Objective: </strong>It was<strong> t</strong>o highlight the importance of adequate nutrological treatment for patients with chronic kidney disease.<strong> Methods: </strong>The systematic review rules of the PRISMA Platform were followed. The research was carried out from August to September 2024 in Scopus, PubMed, Science Direct, Scielo, and Google Scholar databases. The quality of the studies was based on the GRADE instrument and the risk of bias was analyzed according to the Cochrane instrument.<strong> Results and Conclusion: </strong>124 articles were found. 22 articles were evaluated and 18 were included in this systematic review. Considering the Cochrane tool for risk of bias, the overall assessment resulted in 28 studies with a high risk of bias and 22 studies that did not meet GRADE. Most studies showed homogeneity in their results, with X<sup>2</sup> =84.6% >50%. It was concluded that chronic kidney disease is a growing health crisis in the world, accompanying the increase in the number of patients with obesity. Diabetes and hypertension are the main causes of the development of chronic kidney disease. Lifestyle changes, adequate nutritional therapy, and lipid-lowering medications can contribute to improving the clinical outcome of patients with chronic kidney disease. Medical nutritional therapy is fundamental and vital for the treatment of chronic kidney disease, as it can delay disease progression and prevent comorbidities and mortality.</p>Milena de Souza Vasconcelos, Marina dos Santos Gomes Monteiro, Anita Leme da Rocha Saldanha, Tânia Leme da Rocha Martinez, Ana Paula Pantoja Margeotto, Giulia Mitsuko Schmit Hatae, André Luis Valera Gasparoto, Natália Rodrigues Daniel
Copyright (c) 2024 Milena de Souza Vasconcelos, Marina dos Santos Gomes Monteiro, Anita Leme da Rocha Saldanha, Tânia Leme da Rocha Martinez, Ana Paula Pantoja Margeotto, Giulia Mitsuko Schmit Hatae, André Luis Valera Gasparoto, Natália Rodrigues Daniel
https://creativecommons.org/licenses/by/4.0
https://ijn.zotarellifilhoscientificworks.com/index.php/ijn/article/view/396Fri, 15 Nov 2024 00:00:00 +0000Anais do XXVIII Congresso Brasileiro de Nutrologia - n. 28, v. 1, 2024
https://ijn.zotarellifilhoscientificworks.com/index.php/ijn/article/view/395
<p><span class="fontstyle0">O Congresso Brasileiro de Nutrologia, maior evento da área na América Latina e do mundo, está na sua 28ª edição.</span></p> <p><span class="fontstyle0">O CBN 2024 tem como missão prover articulação entre os mais renomados palestrantes nacionais e internacionais, juntamente com os profissionais da saúde - acadêmicos, médicos, nutricionistas, psicólogos - com o objetivo de transmitir conhecimento e atualização sobre os mais variados temas que envolvem nossa especialidade.</span></p> <p><span class="fontstyle0">Nesse contexto, é de grande valia que os novos conhecimentos científicos que estão sendo produzido pela comunidade acadêmica, envolvidos pela Nutrologia em todo o país, sejam compartilhados.</span></p> <p><span class="fontstyle0">Dessa forma, além das conferências e palestras, foram selecionados 363 trabalhos, que estão publicados nesses Anais, e 10 foram escolhidos para serem apresentados oralmente durante o evento. Toda esta difusão de conhecimento enriquecerá ainda mais o CBN 2024.</span> </p>Carlos Alberto Nogueira-de-Almeida, Durval Ribas-Filho
Copyright (c) 2024 Carlos Alberto Nogueira-de-Almeida, Durval Ribas-Filho
https://creativecommons.org/licenses/by/4.0
https://ijn.zotarellifilhoscientificworks.com/index.php/ijn/article/view/395Thu, 14 Nov 2024 00:00:00 +0000Major clinical outcomes and discussions of the impacts of religiousity/spirituality in patients with palliative care and nutrology therapy: a concise systematic review
https://ijn.zotarellifilhoscientificworks.com/index.php/ijn/article/view/392
<p><strong>Introduction:</strong> In the scenario of nutritional therapy and religiosity/spirituality (R/S), several factors can impact the nutritional status of patients in palliative care. These include knowledge of nutrition, the level of emotional support required for the patient, their motivation, and the nature, impact, and severity of the illness. A diet suitable for weight stabilization provides patients with the energy necessary to meet physical, psychological, social, and R/E aspects. <strong>Objective:</strong> It was to carry out a concise systematic review to present the main clinical outcomes and discussions about the impacts of religiosity/spirituality in patients with palliative care undergoing nutritional therapy. <strong>Methods:</strong> The PRISMA Platform systematic review rules were followed. The search was carried out from August to October 2024 in the Scopus, PubMed, Science Direct, Scielo, and Google Scholar databases. The quality of the studies was based on the GRADE instrument and the risk of bias was analyzed according to the Cochrane instrument. <strong>Results and Conclusion:</strong> A total of 91 articles were found, and 24 articles were evaluated in full, and 17 were included and developed in the present systematic review study. Considering the Cochrane tool for risk of bias, the overall assessment resulted in 15 studies with a high risk of bias and 25 studies that did not meet GRADE and AMSTAR-2. Most studies showed homogeneity in their results, with X<sup>2</sup>=72.8%>50%. It was concluded that when the natural oral intake of food and liquids is disturbed, the role of caregivers is to assist the patient in covering the individual's nutritional needs through nutritional therapy and religiosity and spirituality as metabolic and immunological stimuli. Nutritional therapy requires indication to achieve a treatment goal and informed consent from the patient. The suspension and withdrawal of nutritional therapy and artificial hydration must be evaluated in specific situations (terminally ill, palliative care, dementia, elderly patients) and always on a case-by-case basis, according to the cultural and spiritual needs of the patients. Caregivers must emphasize the right to self-determination and therefore respect the patient's autonomy, and also the particular vulnerability of the patient who suffers from or is at risk of malnutrition.</p>Julian Yin Vieira Borges
Copyright (c) 2024 Julian Yin Vieira Borges
https://creativecommons.org/licenses/by/4.0
https://ijn.zotarellifilhoscientificworks.com/index.php/ijn/article/view/392Thu, 17 Oct 2024 00:00:00 +0000Anorexics and saints
https://ijn.zotarellifilhoscientificworks.com/index.php/ijn/article/view/394
<p>In the Middle Ages, some Catholic saints fasted frequently. The specialized literature invariably has a critical bias, as if they suffered from a psychopathology. This article counters this view based on Theology, Catholic Doctrine, and Nutrology.</p>Claudio de Lima Barbosa
Copyright (c) 2024 Claudio de Lima Barbosa
https://creativecommons.org/licenses/by/4.0
https://ijn.zotarellifilhoscientificworks.com/index.php/ijn/article/view/394Wed, 16 Oct 2024 00:00:00 +0000Clinical evidence of low-calorie and ketogenic nutrological therapy before, during and after bariatric surgery: a systematic review
https://ijn.zotarellifilhoscientificworks.com/index.php/ijn/article/view/393
<p><strong>Introduction:</strong> Obesity is a multifactorial disease that causes serious comorbidities. There are more than 2.2 billion overweight and obese people in the world. Obese patients tend to be predisposed to micronutrient deficiency even before bariatric surgery, therefore, it is imperative to supplement nutrients orally, enterally, or parenterally, according to the indications of each patient. <strong>Objective:</strong> It was highlighted the importance of low-calorie and ketogenic nutritional therapy before, during, and after bariatric surgery through the systematic analysis of clinical studies. <strong>Methods:</strong> The systematic review rules of the PRISMA Platform were followed. The search was conducted from June to July 2024 in the Scopus, PubMed, Science Direct, Scielo, and Google Scholar databases. The quality of the studies was based on the GRADE instrument and the risk of bias was analyzed according to the Cochrane instrument. <strong>Results and Conclusion:</strong> 119 articles were found. A total of 40 articles were fully evaluated and 34 were included and developed in the present systematic review study. Considering the Cochrane tool for risk of bias, the overall assessment resulted in 23 studies with a high risk of bias and 27 that did not meet GRADE and AMSTAR-2. Most studies presented homogeneity in their results, with X<sup>2</sup>=76.5%>50%. It was concluded that nutrological therapy strategies could represent a possible alternative to other methodologies, especially when it is recommended to improve patient adherence to following the prescribed diet before bariatric surgery. Weight loss induced by the ketogenic diet before bariatric surgery has beneficial effects on reducing liver volume, metabolic profile, and intra- and postoperative complications. Knowledge of the type of bariatric surgery performed and an understanding of its anatomy and physiology are useful to provide optimal care to patients, especially in nutritional complications. Nutritional deficiencies and metabolic disorders result from “malabsorption” procedures such as RYGB. Immediate administration of thiamine is essential. Dextrose should be avoided in intravenous hydration until thiamine is adequately replaced. For all bariatric patients, a protein intake of 60-70 g/d and a multivitamin with iron and vitamin B12 supplementation is recommended. Daily calcium and vitamin D supplementation is also encouraged. In addition, serum micronutrient levels should be monitored regularly and additional supplementation should be prescribed as indicated.</p>Marília de Andrade Salvá, Mateus Antunes Nogueira, Hugo Menezes Lopes, Márcia Cavalheiro Alves, Ricardo de Oliveira Carvalho, Ana Claudia Santana Cano, Vittor Cândido Soares, Frederico Teixeira Izidorio, Juliana da Silva Pereira, Thamyres Veras Alves
Copyright (c) 2024 Marília de Andrade Salvá, Mateus Antunes Nogueira, Hugo Menezes Lopes, Márcia Cavalheiro Alves, Ricardo de Oliveira Carvalho, Ana Claudia Santana Cano, Vittor Cândido Soares, Frederico Teixeira Izidorio, Juliana da Silva Pereira, Thamyres Veras Alves
https://creativecommons.org/licenses/by/4.0
https://ijn.zotarellifilhoscientificworks.com/index.php/ijn/article/view/393Wed, 02 Oct 2024 00:00:00 +0000Importance of melatonin and its supplementation in the treatment of obesity, inflammatory processes, non-alcoholic hepatic steatosis, and hepatocellular carcinoma: a systematic review
https://ijn.zotarellifilhoscientificworks.com/index.php/ijn/article/view/391
<p><strong>Introduction:</strong> There are more than 2.3 billion overweight and obese people in the world. One of the important neurohormones responsible for adipose tissue metabolism is melatonin (N-acetyl-5-methoxytryptamine) (MEL), which can modulate inflammatory processes by eliminating nitric oxide, reducing synthesis or inhibiting other pro-inflammatory mediators, including tumor necrosis factor-alpha (TNF-a), interleukin 6 (IL-6) and interleukin 8 (IL-8). <strong>Objective:</strong> It was to highlight the main considerations and clinical evidence of the importance of melatonin and its supplementation in the treatment of obesity, inflammatory processes, non-alcoholic fatty liver disease, and hepatocellular carcinoma. <strong>Methods:</strong> The systematic review rules of the PRISMA Platform were followed. The search was carried out from May to July 2024 in the Scopus, PubMed, Science Direct, Scielo, and Google Scholar databases. The quality of the studies was based on the GRADE instrument and the risk of bias was analyzed according to the Cochrane instrument. <strong>Results and Conclusion:</strong> A total of 115 articles were found. A total of 28 articles were evaluated and 25 were included in this systematic review. Considering the Cochrane tool for risk of bias, the overall assessment resulted in 18 studies with a high risk of bias and 25 studies that did not meet the GRADE. Most studies presented homogeneity in their results, with X<sup>2</sup>=85.7%>50%. It was concluded that obesity-related inflammation is related to a state of oxidative stress with high production of reactive oxygen species. Melatonin has been highlighted for its antioxidant and anti-inflammatory properties. The high prevalence of obesity in the world population also confers an increased risk for the development of non-alcoholic fatty liver disease (NAFLD), as well as other liver diseases including hepatocellular carcinoma (HCC). Studies involving drug and molecular therapies are proposed to control the progression of these diseases. It is necessary to perform a molecular analysis involving epigenetic, biochemical, and inflammatory aspects related to melatonin supplementation, clarifying the effect of melatonin supplementation on obesity and liver diseases, including NAFLD and HCC. Thus, it is highlighted that the antioxidant and anti-inflammatory effect of melatonin is essential as a synergistic agent in weight loss and as prophylaxis and/or treatment of liver diseases.</p>Thaysa Andressa Brandão Vilela Teixeira, Luciene Pereira de Oliveira, Maria Aparecida Orlando de Moraes Ferreira, Priscila Mendes Maia Rocha, Gabriela Ricardi, Katia Alves Ramos, Cristiane Reis e Lopes Telles, Antonio Carlos da Silva Junior, Ariadne Fonseca Carvalho Silva, Eduardo Vinicius França Moreira
Copyright (c) 2024 Thaysa Andressa Brandão Vilela Teixeira, Luciene Pereira de Oliveira, Maria Aparecida Orlando de Moraes Ferreira, Priscila Mendes Maia Rocha, Gabriela Ricardi, Katia Alves Ramos, Cristiane Reis e Lopes Telles, Antonio Carlos da Silva Junior, Ariadne Fonseca Carvalho Silva, Eduardo Vinicius França Moreira
https://creativecommons.org/licenses/by/4.0
https://ijn.zotarellifilhoscientificworks.com/index.php/ijn/article/view/391Mon, 30 Sep 2024 00:00:00 +0000Major outcomes in heart failure and cardiovascular diseases of the use of vitamin D, ubiquinone, and magnesium in nutrological cardiology: a systematic review
https://ijn.zotarellifilhoscientificworks.com/index.php/ijn/article/view/390
<p><strong>Introduction:</strong> Heart failure (HF) and cardiovascular diseases (CVD) are the main causes of death in the population. According to data from the World Health Organization for 2023, of the 21.5 million deaths from these diseases. The beneficial metabolic effects of magnesium, vitamin D, and ubiquinone (coenzyme Q10) can be highlighted. <strong>Objective:</strong> It was to scientifically analyze the influence of the three elements Magnesium, Vitamin D, and ubiquinone (Coenzyme Q10) concerning heart failure, cardiovascular diseases and metabolic syndrome. <strong>Methods:</strong> The systematic review rules of the PRISMA Platform were followed. The research was carried out from June to July 2024 in Scopus, PubMed, Science Direct, Scielo, and Google Scholar databases. The quality of the studies was based on the GRADE instrument and the risk of bias was analyzed according to the Cochrane instrument. <strong>Results and Conclusion:</strong> A total of 154 articles were found, and 80 articles were evaluated and 78 were included in this systematic review. Considering the Cochrane tool for risk of bias, the overall assessment resulted in 18 studies with a high risk of bias and 26 studies that did not meet GRADE. Most studies showed homogeneity in their results, with I<sup>2</sup> =96.8% >50%. It was concluded that magnesium plays a fundamental role in glucose metabolism, insulin, and glycemic homeostasis, in the synthesis of adenosine triphosphate, proteins, and nucleic acids. However, further studies are needed to better clarify the role of magnesium in the prevention and treatment of cardiovascular diseases, especially concerning higher concentrations and increased treatment time. Vitamin D plays important roles in innate and adaptive immune responses, cell cycle, and metabolic processes, evidenced by the reported relationship between its deficiency and the prevalence of immune-mediated disorders, cancer, and cardiometabolic diseases. Coenzyme Q10 exerts an important protective antioxidant action. Clinical studies carried out showed that pathologies such as acute myocardial infarction, arterial hypertension, myopathies induced by statins, physical fatigue inherent to physical exercise, male infertility, pre-eclampsia, Parkinson's disease, periodontal diseases, and migraines had low plasma concentrations of Q10. In addition, Coenzyme Q10 reduces the amount of lipid peroxide found in atherosclerotic lesions. Thus, Q10 protects the lipids present in cell membranes, as well as plasma lipoproteins.</p>Divina Seila de Oliveira, Sarah Rachel Pereira de Moura Lima, Lucila Maria de Almeida Lopes, Ricardo de Oliveira Carvalho, Simone Drbal de Oliveira, Vittor Cândido Soares, Jefferson Alexandre Azevedo de Araujo, Karlla Gabrielly Claudino Santos, Sarah Bernardon de Oliveira, Hugo Menezes Lopes
Copyright (c) 2024 Divina Seila de Oliveira, Sarah Rachel Pereira de Moura Lima, Lucila Maria de Almeida Lopes, Ricardo de Oliveira Carvalho, Simone Drbal de Oliveira, Vittor Cândido Soares, Jefferson Alexandre Azevedo de Araujo, Karlla Gabrielly Claudino Santos, Sarah Bernardon de Oliveira, Hugo Menezes Lopes
https://creativecommons.org/licenses/by/4.0
https://ijn.zotarellifilhoscientificworks.com/index.php/ijn/article/view/390Fri, 27 Sep 2024 00:00:00 +0000Major clinical outcomes of nutrology management and the endocannabinoid system in the performance of paralympic athletes: a systematic review
https://ijn.zotarellifilhoscientificworks.com/index.php/ijn/article/view/389
<p><strong>Introduction:</strong> In the Paralympic sports scenario, recent research suggests that the connection between nutrients and the intestinal microbiota may play an important role in athlete health and performance. Exercise-induced extracellular vesicles (exosomes and microRNAs) have emerged as potential mediators of muscle crosstalk. Furthermore, clinical studies suggest that cannabidiol (CBD) may be useful for athletes due to its anti-inflammatory, analgesic, anxiolytic, and neuroprotective properties and its influence on the sleep-wake cycle. As a corollary of this, a series of implications of cannabidiol in gene expression processes modulated by microRNAs are being evidenced, impacting the immune and inflammatory systems in athletes. <strong>Objective:</strong> This study aimed to present the main clinical outcomes of nutritional management and the endocannabinoid system in the performance of Paralympic athletes through a systematic review. <strong>Methods:</strong> The systematic review rules of the PRISMA Platform were followed. The search was realized from June to July 2024 in the Scopus, PubMed, Science Direct, Scielo, and Google Scholar databases. The quality of the studies was based on the GRADE instrument and the risk of bias was analyzed according to the Cochrane instrument. <strong>Results and Conclusion:</strong> 135 articles were found. A total of 28 articles were evaluated and 25 were included in this systematic review. Considering the Cochrane tool for risk of bias, the overall assessment resulted in 18 studies with a high risk of bias and 25 studies that did not meet GRADE and AMSTAR-2. Most of the studies presented homogeneity in their results, with X<sup>2</sup> = 87.5% >50%. It was concluded that Paralympic athletes should feed, train, and utilize the entire supraorganism, including the intestinal microbiota, implementing gut-centered dietary strategies to achieve optimal performance. Current evidence suggests that the gut microbiota may contribute to sports performance through the production of nutritional metabolites (short-chain fatty acids, secondary bile acids), influence on gastrointestinal physiology (nutrient absorption), and immune modulation (inhibition of pathogens). Intake of adequate dietary fiber, a variety of protein sources, and emphasis on unsaturated fats, especially ɷ-3 fatty acids, as well as supplementation with pre-, pro-, and synbiotics, have shown promising results in optimizing the health of Paralympic athletes and with potential beneficial effects on performance. Furthermore, there is preliminary evidence supporting the anti-inflammatory, neuroprotective, analgesic, and anxiolytic actions of cannabidiol and the possibility that it may protect against gastrointestinal damage associated with inflammation and promote the healing of traumatic skeletal injuries. A specific repertoire of microRNAs regulated by cannabinoids in resting (vigilant) and lipopolysaccharide-activated microglia has been identified. The modulated microRNAs and their target genes are controlled by TLR, Nrf2, and Notch cross-talk and are involved in immune response, cell cycle regulation, cellular stress, and redox homeostasis.</p>Vitor Bezerra de Medeiros, Kennya Medeiros Lopes de Barros Lima, Ana Gabriela de Magalhães, Laís Martins Borges, Karlla Gabrielly Claudino Santos, Leonardo Honório de Andrade Mélo Neto, Hugo Menezes Lopes, Jeffeson Alexandre Azevedo de Araujo, Diego Pereira Netto, Brysa Freitas Dall’orto, Nicole Velasco Campos
Copyright (c) 2024 Vitor Bezerra de Medeiros, Kennya Medeiros Lopes de Barros Lima, Ana Gabriela de Magalhães, Laís Martins Borges, Karlla Gabrielly Claudino Santos, Leonardo Honório de Andrade Mélo Neto, Hugo Menezes Lopes, Jeffeson Alexandre Azevedo de Araujo, Diego Pereira Netto, Brysa Freitas Dall’orto, Nicole Velasco Campos
https://creativecommons.org/licenses/by/4.0
https://ijn.zotarellifilhoscientificworks.com/index.php/ijn/article/view/389Thu, 26 Sep 2024 00:00:00 +0000Major approaches to endoscopic treatment of gastrojejunal anastomosis post gastric bypass with argon plasma and dietary monitoring: a systematic review
https://ijn.zotarellifilhoscientificworks.com/index.php/ijn/article/view/388
<p><strong>Introduction:</strong> Obesity is a serious chronic non-communicable disease (NCD) that has several consequences for public health. In this scenario, there are more than 2.2 billion people who are overweight or obese in the world, and the latest census showed that Brazil is in fifth place in the world ranking with 18.0 million obese individuals, tending to reach 70.0 million patients. Roux-en-Y Gastric Bypass (RYGB) is one of the most performed surgeries in the world, however, approximately 20% of patients undergoing this surgery do not lose the desired weight in the first year and 15% of patients regain weight after 18 to 24 months. Anastomotic diameters above 15.0 mm have been associated with a recurrence of obesity and may be associated with complaints of decreased satiety. Thus, the application of argon plasma in gastrojejunal anastomosis has been proposed to reduce weight in patients undergoing RYGB who presented recurrent obesity. <strong>Objective:</strong> It was to develop current scientific approaches through a systematic review of the main approaches and application of argon plasma and dietary monitoring in the reduction of dilated gastrojejunal anastomosis and the consequent reduction of recurrent weight after gastric bypass. <strong>Methods:</strong> The research and development of the work were carried out from May to July 2024 in the Scopus, PubMed, Science Direct, and Scielo databases, using the main scientific articles on nutrigenomics, and following the PRISMA rules. The quality of the studies was based on the GRADE and AMSTAR-2 instruments, and the risk of bias by the Cochrane instrument (Funnel Plot). <strong>Results and Conclusion:</strong> Twentyone studies were included out of a total of 125. According to the GRADE instrument, most studies presented homogeneity in their results, with X<sup>2</sup>=88.6%>50%. Considering the Cochrane tool for risk of bias, the overall assessment resulted in 37 studies with a high risk of bias and 25 studies that did not meet the GRADE and AMSTAR-2 criteria. The application of argon plasma in the treatment of dilated gastrojejunal anastomosis and dietary monitoring have been highlighted as effective and safe methods in the treatment of recurrent obesity. The application of argon plasma via an endoscopic approach is very effective in its indications, technically easy to perform, and has numerous advantages over conventional electrocoagulation. Complications are rare. The limit of tissue penetration depth of 2 to 3 mm associated with excellent coagulation allows its application in critical areas such as the duodenum and colon.</p>Kennya Medeiros Lopes de Barros Lima, Ana Gabriela de Magalhães, Laís Martins Borges, Karlla Gabrielly Claudino Santos, Leonardo Honório de Andrade Mélo Neto, Vitor Bezerra de Medeiros, Hugo Menezes Lopes, Jeffeson Alexandre Azevedo de Araujo, Diego Pereira Netto, Brysa Freitas Dall’orto, Nicole Velasco Campos
Copyright (c) 2024 Kennya Medeiros Lopes de Barros Lima, Ana Gabriela de Magalhães, Laís Martins Borges, Karlla Gabrielly Claudino Santos, Leonardo Honório de Andrade Mélo Neto, Vitor Bezerra de Medeiros, Hugo Menezes Lopes, Jeffeson Alexandre Azevedo de Araujo, Diego Pereira Netto, Brysa Freitas Dall’orto, Nicole Velasco Campos
https://creativecommons.org/licenses/by/4.0
https://ijn.zotarellifilhoscientificworks.com/index.php/ijn/article/view/388Thu, 26 Sep 2024 00:00:00 +0000Nutritional therapies in patients with obesity in controlling gene expression of microRNAs for reducing inflammatory processes and metabolic disorders: a systematic review
https://ijn.zotarellifilhoscientificworks.com/index.php/ijn/article/view/387
<p><strong>Introduction:</strong> In the context of the obesity pandemic, an estimated 3.0 billion patients have excessive reserves of adipose tissue and calories. These patients with excess energy are not classified as overweight or obese. Increasing evidence suggests that obesity promotes the activation of resident T cells and macrophages. MicroRNAs contribute to the maintenance of the immune response and obesity in adipose tissue, and enteral nutritional therapy is essential for the treatment of obesity, as it works as triggers to modulate gene expression through microRNAs. <strong>Objective:</strong> This study aimed to present the main considerations of enteral nutritional therapy in patients with obesity, in controlling the gene expression of microRNAs in the gut microbiota, adipose tissue, and circulatory systems to reduce inflammatory processes, and metabolic disorders. <strong>Methods:</strong> The systematic review rules of the PRISMA Platform were followed. The research was carried out from May to July 2024 in the Scopus, PubMed, Science Direct, Scielo, and Google Scholar databases. The quality of the studies was based on the GRADE instrument and the risk of bias was analyzed according to the Cochrane instrument. <strong>Results and Conclusion:</strong> A total of 127 articles were found. A total of 38 articles were fully evaluated and 17 were included in this systematic review. Considering the Cochrane tool for risk of bias, the overall assessment resulted in 20 studies with high risk of bias and 23 studies that did not meet the GRADE. Most studies showed homogeneity in their results, with X<sup>2</sup>=73.5% >50%. It was concluded that certain miRNAs have been implicated in the control of body weight gain, glucose homeostasis, insulin resistance and lipid metabolism. A single dose of dietary protein has acute effects on hormonal and metabolic regulation and increases the expression of exosomal miRNA in individuals with obesity and insulin resistance. Enteral feeding is an effective and safe treatment in the regulation of these microRNAs. Ketogenic enteral nutrition may lead to better clinical outcomes than hypocaloric enteral nutritional protocols in glycemic and lipid profiles. A diverse range of nutritional interventions have been shown to be effective in the treatment of obesity and its comorbidities, mainly through the modulation of nutritherapy on microRNAs in adipose tissue, intestinal microbiota and circulatory systems.</p>Suzana Viana de Moura Batalha
Copyright (c) 2024 Suzana Viana de Moura Batalha
https://creativecommons.org/licenses/by/4.0
https://ijn.zotarellifilhoscientificworks.com/index.php/ijn/article/view/387Sat, 21 Sep 2024 00:00:00 +0000Major clinical evidence on the use of low-dose naltrexone in the treatment of cancer: a systematic review
https://ijn.zotarellifilhoscientificworks.com/index.php/ijn/article/view/386
<p><strong>Introduction:</strong> Opioid receptors are groups of receptors (γ-, κ-, δ-, and ζ-opioid receptors) that are widely distributed in nerve cells in the brain, spinal cord, and digestive tract. Naltrexone is a type of general opioid receptor antagonist. It has been used to treat chronic pain syndrome, autoimmune diseases, and cancer at a dose of 5 mg/day, which is generally called low-dose naltrexone (LDN). <strong>Objective:</strong> It was to analyze the pharmacological functions of low-dose naltrexone, especially in anti-inflammation and immunoregulation, and its therapeutic potential against cancer. <strong>Methods:</strong> The research and development of the work were carried out from June to July 2024 in the Scopus, PubMed, Science Direct, and Scielo databases, using scientific articles from the last 15 years, following the PRISMA rules. The quality of the studies was based on the GRADE and AMSTAR2 instruments, and the risk of bias was assessed using the Cochrane instrument (Funnel Plot). <strong>Results and Conclusion:</strong> Fifteen studies were included in the systematic review out of 30. Most studies showed homogeneity in their results, with X<sup>2</sup>=94.5%>50%. Low-dose naltrexone has immunomodulatory and therapeutic effects. Low-dose naltrexone regulates the production of inflammatory cytokines, influencing the level of endogenous opioid peptides in the body. Furthermore, low-dose naltrexone has an antitumor effect and can modulate the neuroblastoma tumor response, delaying the onset and reducing the incidence rate of tumors, significantly decreasing tumor volume and weight, and DNA synthesis in cancer.</p>Luciene Pereira de Oliveira, Maria Aparecida Orlando de Moraes Ferreira, Priscila Mendes Maia Rocha, Gabriela Ricardi, Katia Alves Ramos, Cristiane Reis e Lopes Telles, Antonio Carlos da Silva Junior, Ariadne Fonseca Carvalho Silva, Thaysa Andressa Brandão Vilela Teixeira, Eduardo Vinicius França Moreira
Copyright (c) 2024 Luciene Pereira de Oliveira, Maria Aparecida Orlando de Moraes Ferreira, Priscila Mendes Maia Rocha, Gabriela Ricardi, Katia Alves Ramos, Cristiane Reis e Lopes Telles, Antonio Carlos da Silva Junior, Ariadne Fonseca Carvalho Silva, Thaysa Andressa Brandão Vilela Teixeira, Eduardo Vinicius França Moreira, Moniquy Quintela Orlando de Moraes, Amarildo Aparecido Ferreira Júnior
https://creativecommons.org/licenses/by/4.0
https://ijn.zotarellifilhoscientificworks.com/index.php/ijn/article/view/386Fri, 20 Sep 2024 00:00:00 +0000Health promotion through the adoption of the mediterranean diet as a therapeutic proposal in the treatment and prevention of metabolic syndrome: a systematic review
https://ijn.zotarellifilhoscientificworks.com/index.php/ijn/article/view/385
<p><strong>Introduction:</strong> Excessive weight gain generates comorbidities, many of which are characterized as metabolic syndrome (MetS). It is important to highlight the association of MetS with cardiovascular diseases, increasing global mortality by approximately 1.5 times and cardiovascular mortality by approximately 2.5 times. In this sense, the Mediterranean diet presents itself as the main therapeutic proposal in the treatment of MetS, as it corresponds to caloric limitations without altering the patient's adequate nutritional status. <strong>Objective:</strong> It was to investigate the effects of health promotion through the adoption of the Mediterranean diet as a therapeutic proposal in the treatment and prevention of metabolic syndrome, evaluating the nutritional benefit on quality of life. <strong>Methods:</strong> The PRISMA Platform systematic review rules were followed. The research was carried out from April to June 2024 in the Scopus, PubMed, Science Direct, Scielo, and Google Scholar databases. The quality of the studies was based on the GRADE instrument and the risk of bias was analyzed according to the Cochrane instrument. <strong>Results and Conclusion:</strong> 157 articles were found. A total of 26 articles were evaluated in full and 21 were included and developed in the present systematic review study. Considering the Cochrane tool for risk of bias, the overall assessment resulted in 29 studies with a high risk of bias and 28 studies that did not meet GRADE and AMSTAR-2. It was concluded that the studies showed the beneficial effects of the Mediterranean diet in reducing the prevalence of MetS. Furthermore, the dietary pattern described in the Mediterranean diet combined with physical activities can be used as a useful clinical tool in the treatment of metabolic syndrome. The suggested menu, with foods rich in fiber, is associated with reducing cardiovascular risk and, therefore, the Mediterranean diet is recognized as an agent for promoting health and preventing and treating obesity. In this sense, it appears that dietary factors can play a fundamental role both in the individual components and in the prevention and control of metabolic syndrome. Recent data associate the presence of MetS with lower consumption of whole grains, fruits, and vegetables. Therefore, there is a close relationship between these foods and dietary fiber, and, probably, soluble fiber is more directly related to these effects. A reduced prevalence of MetS was also observed in patients with systemic lupus erythematosus, a result of the good level of adherence to the Mediterranean diet. Furthermore, 25(OH)D status is associated with the composition, diversity, and functionality of the gut microbiota, and lifestyle intervention can modulate both the gut microbiota and 25(OH)D levels, potentially influencing metabolic pathways.</p>Maria Aparecida Orlando de Moraes Ferreira, Priscila Mendes Maia Rocha, Luciene Pereira de Oliveira, Gabriela Ricardi, Katia Alves Ramos, Cristiane Reis e Lopes Telles, Antonio Carlos da Silva Junior, Ariadne Fonseca Carvalho Silva, Thaysa Andressa Brandão Vilela Teixeira, Eduardo Vinicius França Moreira, Moniquy Quintela Orlando de Moraes, Amarildo Aparecido Ferreira Júnior
Copyright (c) 2024 Maria Aparecida Orlando de Moraes Ferreira, Priscila Mendes Maia Rocha, Luciene Pereira de Oliveira, Gabriela Ricardi, Katia Alves Ramos, Cristiane Reis e Lopes Telles, Antonio Carlos da Silva Junior, Ariadne Fonseca Carvalho Silva, Thaysa Andressa Brandão Vilela Teixeira, Eduardo Vinicius França Moreira, Moniquy Quintela Orlando de Moraes, Amarildo Aparecido Ferreira Júnior
https://creativecommons.org/licenses/by/4.0
https://ijn.zotarellifilhoscientificworks.com/index.php/ijn/article/view/385Fri, 20 Sep 2024 00:00:00 +0000Major evidence of nutritional and metabolic management in the context of bariatric surgery: a systematic review
https://ijn.zotarellifilhoscientificworks.com/index.php/ijn/article/view/384
<p><strong>Introduction:</strong> Approximately $315 billion is spent annually on the medical cost of obesity in adult patients in the United States alone. According to the American Society for Metabolic and Bariatric Surgery (ASMBS), the rate of bariatric surgery (BS) increased from 158,000 in 2011 to 196,000 in 2015. This increase in invasive techniques does not eliminate unhealthy habits, therefore, lifestyle modifications, such as healthy eating and correct physical activity programs, can improve surgical results. <strong>Objective:</strong> To establish the main nutritional and metabolic management strategies in the context of bariatric surgery, to modulate and reduce the problems caused by nutrient deficit. <strong>Methods:</strong> The systematic review rules of the PRISMA Platform were followed. The search was conducted from May to June 2024 in the Web of Science, Scopus, PubMed, Science Direct, Scielo, and Google Scholar databases. The quality of the studies was based on the GRADE instrument and the risk of bias was analyzed according to the Cochrane instrument. <strong>Results and Conclusion:</strong> A total of 135 articles were found. 42 articles were fully evaluated and 18 were included and developed in the present systematic review study. Considering the Cochrane tool for risk of bias, the overall assessment resulted in 22 studies with a high risk of bias and 24 that did not meet GRADE and AMSTAR-2. Most studies presented homogeneity in their results, with X<sup>2</sup>=79.7%>50%. It was concluded that the recommendations were gathered to assist in individualized clinical practice in the nutritional management of patients with obesity. In general, patients with obesity have significantly lower concentrations of serum iron, folic acid, vitamins A, B6, B12, C, 25-hydroxyvitamin D, and lipid-standardized vitamin E. Before bariatric surgery, nutritional status should be analyzed and preoperative weight loss can be attempted. Very low-calorie diets and very low-calorie ketogenic diets are prescribed in the last months before surgery. It was noted that the recommendations were gathered to assist in individualized clinical practice in the nutritional management of patients with obesity, including nutritional management. Iron status may be affected by adipose tissue inflammation and increased expression of the systemic iron regulatory protein hepcidin. The postoperative recommendation for vitamin B12 (cobalamin) should be 350-500 micrograms/1000 micrograms monthly, and for folate (folic acid) in the postoperative period should be 1000 micrograms per day.</p>Ana Angélica Nogueira Lima, Hélida Maria Bezerra, Marcelo Rodrigues Zacarkim, Firmino Lucas Barreto de Matos Nobre, Ana Gabriella de Almeida Araújo, Lucila Maria de Almeida Lopes, Lara Maria Vilaça de Figueiredo, José de Sousa Xavier
Copyright (c) 2024 Ana Angélica Nogueira Lima, Hélida Maria Bezerra, Marcelo Rodrigues Zacarkim, Firmino Lucas Barreto de Matos Nobre, Ana Gabriella de Almeida Araújo, Lucila Maria de Almeida Lopes, Lara Maria Vilaça de Figueiredo, José de Sousa Xavier
https://creativecommons.org/licenses/by/4.0
https://ijn.zotarellifilhoscientificworks.com/index.php/ijn/article/view/384Tue, 17 Sep 2024 00:00:00 +0000MDPL syndrome (mandibular hypoplasia, deafness, progeroid features, and lipodystrophy) and nutrological management: a rare case report
https://ijn.zotarellifilhoscientificworks.com/index.php/ijn/article/view/383
<p><strong>Introduction:</strong> Congenital lipodystrophies comprise a rare group of heterogeneous disorders that affect adipose tissue distributions and are characterized by varying degrees of body fat loss. Genetic damage, telomere shortening, cellular senescence, and proliferation defects are hallmarks of the aging process. Metabolism and mitochondrial activity play an important role in the pathogenesis of MDPL syndrome (mandibular hypoplasia, deafness, progeroid features, and lipodystrophy). <strong>Objective:</strong> It was to report the case and diagnosis of a patient with MDPL syndrome and the nutrological management. <strong>Case report:</strong> The information was obtained during the patient's medical consultation with the author, interview with the patient and family, photographic record, and literature review. This study followed ethics committee compliance and preserved the patient's anonymity, as well as the patient's rights and care, as per the 1964 Declaration of Helsinki. The total fat percentage of 32% (54th percentile), a very low relative musculoskeletal index of 2.56 kg/m<sup>2</sup>, and also a low fat mass index of 3.89 g/m<sup>2</sup>. Laboratory tests showed a low leptin of 1.90 ng/mL, basal insulin of 166.3 μUI/mL, HOMA IR of 38.2, and triglycerides of 205 mg/dL. Analysis of DNA extracted by oral SWAB was positive for alteration in the POLD1 gene, confirming the diagnosis of MDPL. After initiating treatment with a diet adjusted in proteins, calories, index, and glycemic load, metformin, the patient presented new exams with HOMA-IR 8.3, evolving with a gain of 2.5 kilos, now with 33.1 kilograms of weight, reporting improvement. <strong>Final considerations:</strong> The reported case and raised publications bring to light the discussion of the diagnosis and treatment of a complex syndrome such as MDPL. The absence of a cure, the difficulty in diagnosis, and the unavailability of some of the therapeutic resources make the syndrome of mandibular hypoplasia, deafness, progeroid characteristics, and lipodystrophy an extremely rare syndrome, difficult to diagnose, and difficult to manage. Progress in identifying lipodystrophy genes will help to better understand the role of pathways involved in the complex physiology of fat. Studies have shown mitochondrial dysfunction as well as morphological alterations in mitochondria in patients with MDPL.</p>Limiro Luiz da Silveira Neto
Copyright (c) 2024 Limiro Luiz da Silveira Neto
https://creativecommons.org/licenses/by/4.0
https://ijn.zotarellifilhoscientificworks.com/index.php/ijn/article/view/383Tue, 17 Sep 2024 00:00:00 +0000Major clinical outcomes of nutrology and lifestyle in the metabolic processes of healthy aging: a systematic review
https://ijn.zotarellifilhoscientificworks.com/index.php/ijn/article/view/382
<p><strong>Introduction:</strong> Centenarians exemplify the concept of healthy aging and therefore provide an invaluable resource for identifying novel host-intestinal microbiota relationships concerning aging. Approximately 18 micronutrients, composed of minerals and vitamins, facilitate the optimal utilization of macronutrients through their role in catalyzing numerous biochemical processes, increasing their bioavailability and absorption, and balancing the microbiome. In the context of aging, a major challenge to maintaining health in old age is unbalanced nutritional intake, resulting in nutritional deficiency or malnutrition. <strong>Objective:</strong> The main clinical outcomes of nutrology and lifestyle in the metabolic processes of healthy aging were listed through a systematic review. <strong>Methods:</strong> The systematic review rules of the PRISMA Platform were followed. The search was carried out from July to August 2024 in the Scopus, PubMed, Science Direct, Scielo, and Google Scholar databases. The quality of the studies was based on the GRADE instrument and the risk of bias was analyzed according to the Cochrane instrument. <strong>Results and Conclusion:</strong> A total of 118 articles were found. A total of 39 articles were fully evaluated and 29 were included and developed in the present systematic review study. Considering the Cochrane tool for risk of bias, the overall assessment resulted in 21 studies with a high risk of bias and 15 that did not meet the GRADE and AMSTAR-2 criteria. Most studies showed homogeneity in their results, with X<sup>2</sup>=82.7%>50%. Zinc and copper govern many functions that characterize the so-called “oxy-aging”. Selenium (Se) is a fundamental cofactor in many redox functions, the role of vitamin C in aging has been investigated particularly for skin health and immunity, particularly in inflammatory and degenerative diseases. Retinoids, which represent a synthetic form of vitamin A, appear effective in preventing skin degeneration due to aging. The role of vitamin E in the prevention and reduction of ROS-induced lesions has been well described. Supplementation with selenium and coenzyme Q10 influenced the analyzed biomarkers in a way that indicated an anti-aging effect. It was concluded that an adequate plasma level of trace elements, such as Zn or copper (Cu), promotes an optimal function of the immune response. Selenium (Se) is a key cofactor in many redox functions, which reduces ROS-induced degeneration in the senescent phenotype. The role of vitamin C in aging has been investigated particularly for skin health and immunity, particularly in inflammatory and degenerative diseases. Vitamin A acts in the prevention of skin degeneration due to aging. The role of vitamin E in the prevention and reduction of ROS-induced lesions has been well described, as well as it has been associated with the prevention of cognitive decline during senescence, particularly in Alzheimer's disease. Good fats, vitamins, minerals, or polyphenols can have antioxidant and anti-inflammatory activities, with anti-aging effects. Recent studies have shown that vitamin K is a vital cofactor in the activation of several proteins, which act against age-related syndromes.</p>Sarah Rachel Pereira de Moura Lima, Lucila Maria de Almeida Lopes, Ricardo de Oliveira Carvalho, Simone Drbal de Oliveira, Divina Seila de Oliveira, Vittor Cândido Soares, Jefferson Alexandre Azevedo de Araujo, Karlla Gabrielly Claudino Santos, Sarah Bernardon de Oliveira, Hugo Menezes Lopes
Copyright (c) 2024 Sarah Rachel Pereira de Moura Lima, Lucila Maria de Almeida Lopes, Ricardo de Oliveira Carvalho, Simone Drbal de Oliveira, Divina Seila de Oliveira, Vittor Cândido Soares, Jefferson Alexandre Azevedo de Araujo, Karlla Gabrielly Claudino Santos, Sarah Bernardon de Oliveira, Hugo Menezes Lopes
https://creativecommons.org/licenses/by/4.0
https://ijn.zotarellifilhoscientificworks.com/index.php/ijn/article/view/382Sat, 14 Sep 2024 00:00:00 +0000Major considerations on the relationship of triple negative breast cancer with microRNAs and nutrological triggers: a systematic review
https://ijn.zotarellifilhoscientificworks.com/index.php/ijn/article/view/381
<p><strong>Introduction:</strong> Triple-negative breast cancer (TNBC) accounts for 15% of all cases. Its incidence is usually higher in young women (under 40 years of age). The classification as triple-negative occurs because, in this case, there are no estrogen, progesterone, and HER2 receptors, which are responsible for controlling tumor growth. Higher levels of physical activity and better diet quality are associated with lower mortality from breast cancer in observational studies. Furthermore, physical activity and optimal nutrition can improve the relative dose intensity of chemotherapy, as they can activate miRNAs that regulate several biological processes. <strong>Objective:</strong> This was to conduct a systematic review to establish the main considerations of the relationship between triple-negative breast cancer and microRNAs as biomarkers and regulators of gene expression in cancer cells, as well as to show some nutritional triggers of microRNA activation desirable for breast cancer control. <strong>Methods:</strong> The PRISMA Platform systematic review rules were followed. The search was conducted from April to June 2024 in the Web of Science, Scopus, PubMed, Science Direct, Scielo, and Google Scholar databases. The quality of the studies was based on the GRADE and AMSTAR-2 instrument and the risk of bias was analyzed appropriately. According to the Cochrane instrument. <strong>Results and Conclusion:</strong> 112 articles were found, and 40 were evaluated in full and included in this article, 22 of which were included in the systematic review. Considering the Cochrane tool for risk of bias, the global assessment resulted in 15 studies with a high risk of bias and 25 studies that did not reach GRADE and AMSTAR-2. Most studies showed homogeneity in their results, with X<sup>2</sup>=81.5%>50%. It was concluded that an increasing number of studies have shown that non-coding RNA (ncRNA), including microRNA (miRNA) and long non-coding RNA (lncRNA), play a significant role in tumorigenesis. Although a diet and exercise intervention did not affect relative dose intensity, the intervention was associated with a higher pCR in patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative and triple-negative breast cancer undergoing neoadjuvant chemotherapy. High expression levels of miR-27a/b, miR-210, and miR-454 were associated with shorter overall survival, whereas high expression levels of miR-454 and miR-374a/b were associated with disease-free survival. The miRNAs associated with triple-negative breast cancer may provide new avenues for early diagnosis and treatment of breast cancer. Furthermore, specific miRNAs may serve as potential prognostic biomarkers in triple-negative breast cancer.</p>Márcio do Nascimento Ribeiro, Marla Mayara da Silva Nascimento Ribeiro
Copyright (c) 2024 Márcio do Nascimento Ribeiro, Marla Mayara da Silva Nascimento Ribeiro
https://creativecommons.org/licenses/by/4.0
https://ijn.zotarellifilhoscientificworks.com/index.php/ijn/article/view/381Fri, 13 Sep 2024 00:00:00 +0000Major types of diets in the management of metabolic syndrome and obesity: a systematic review
https://ijn.zotarellifilhoscientificworks.com/index.php/ijn/article/view/380
<p><strong>Introduction:</strong> Excessive weight gain generates comorbidities, many of which are characterized as metabolic syndrome (MS), in which the individual, to be diagnosed, must present three or more metabolic or anthropometric changes such as increased waist circumference, systemic arterial hypertension, hyperglycemia, hypertriglyceridemia, and reduced serum HDL levels. It is important to highlight the association of MS with cardiovascular diseases, increasing global mortality by approximately 1.5 times and cardiovascular mortality by approximately 2.5 times. In this sense, of the different types of diets such as the low-carb diet, very low-carb diet, and intermittent fasting diet, the traditional Brazilian diet, the DASH, and the Mediterranean diet stand out, as they present as the main therapeutic proposal in the treatment of MS. <strong>Objective:</strong> It was to carry out a systematic review to present the main types of diets in the management of metabolic syndrome, evaluating their effectiveness as a nutritional benefit in controlling health and quality of life. <strong>Methods:</strong> The PRISMA Platform systematic review rules were followed. The search was carried out from April to June 2024 in the Web of Science, Scopus, PubMed, Science Direct, Scielo, and Google Scholar databases. The quality of the studies was based on the GRADE and AMSTAR-2 instrument and the risk of bias was analyzed appropriately. according to the Cochrane instrument. <strong>Results and Conclusion:</strong> 111 articles were found, and 30 were evaluated in full and included in this article, 21 of which were included in the systematic review. Considering the Cochrane tool for risk of bias, the global assessment resulted in 12 studies with a high risk of bias and 21 studies that did not reach GRADE and AMSTAR-2. Most studies showed homogeneity in their results, with X<sup>2</sup>=79.8%>50%. It was concluded that the traditional Brazilian diet, DASH, and the Mediterranean diet have in common the characteristics of plant-based diet varieties that incorporate natural foods and reduce ultra-processed foods. These diets have shown good results for human health through the prevention and treatment of obesity in its different life cycles, and there is also evidence of a reduction in the risk of cardiovascular diseases and cancer in individuals with obesity. Furthermore, these diets promote a decrease in low-grade inflammation that affects individuals with obesity, having beneficial effects in reducing metabolic syndrome, even more so when added to physical activities. It has been shown that dietary factors can play a fundamental role both in the individual components and in the prevention and control of metabolic syndrome. Recent data associate the presence of metabolic syndrome with lower consumption of whole grains, fruits, and vegetables.</p>Pedro Luiz Ferreira de Siqueira Júnior, Luciana Corrêa dos Santos Leão
Copyright (c) 2024 Pedro Luiz Ferreira de Siqueira Júnior, Luciana Corrêa dos Santos Leão
https://creativecommons.org/licenses/by/4.0
https://ijn.zotarellifilhoscientificworks.com/index.php/ijn/article/view/380Tue, 10 Sep 2024 00:00:00 +0000Major relationships among nutrology, gut microbiota and lifestyle change in healthy longevity: a systematic review
https://ijn.zotarellifilhoscientificworks.com/index.php/ijn/article/view/379
<p><strong>Introduction:</strong> In the healthy longevity scenario, individuals over 65 and over 80 years old will be the fastest growing segment of the population. This is associated with the intensification of chronic diseases, such as cardiovascular diseases, diabetes, cancer, sarcopenia, and degenerative diseases (non-communicable diseases). Genetic, epigenetic, and lifestyle factors can determine the longevity of humans. Certain healthy foods are associated with longer telomere lengths. <strong>Objective:</strong> To describe, through a systematic literature review, the main relationships between nutrology, gut microbiota, and lifestyle changes in healthy longevity. <strong>Methods:</strong> The systematic review rules of the PRISMA Platform were followed. The search was carried out from May to July 2024 in the Scopus, PubMed, Science Direct, Scielo, and Google Scholar databases. The quality of the studies was based on the GRADE instrument and the risk of bias was analyzed according to the Cochrane instrument. <strong>Results and Conclusion:</strong> 139 articles were found. A total of 51 articles were fully assessed and 22 were included in this systematic review. Considering the Cochrane tool for risk of bias, the overall assessment resulted in 20 studies with a high risk of bias and 32 studies that did not meet GRADE and AMSTAR-2. Most studies showed homogeneity in their results, with X<sup>2</sup> =77.5%>50%. It was concluded that nutrients that can modulate epigenetic pathways, positively influence the outcomes associated with healthy longevity. Studies have shown that the gut microbiota in longlived individuals has a high capacity for lipid metabolism, amino acid degradation, and potential signs of a chronic inflammatory state. Probiotics and prebiotics may be effective alternatives, considering the relationship between the microbiome and healthy aging. Furthermore, resveratrol can modulate epigenetic pathways and may affect outcomes associated with aging, exerting favorable metabolic changes, such as reductions in inflammatory markers or low-density lipoprotein. Nutrients and natural substances of human physiology and biochemistry such as melatonin, coenzyme Q10, and selenium control the functions of the immune and metabolic systems. Many metabolic or chronic diseases have been implicated in poor diet and lifestyle. Improving the quality of diet is associated with reduced mortality from all causes, whereas multivitamin and multimineral supplements can improve life expectancy</p>Mateus Antunes Nogueira, Hugo Menezes Lopes, Márcia Cavalheiro Alves, Ricardo de Oliveira Carvalho, Ana Claudia Santana Cano, Vittor Cândido Soares6, Frederico Teixeira Izidorio, Juliana da Silva a Pereira, Marília de Andrade Salvá, Thamyres Veras Alves
Copyright (c) 2024 Mateus Antunes Nogueira, Hugo Menezes Lopes, Márcia Cavalheiro Alves, Ricardo de Oliveira Carvalho, Ana Claudia Santana Cano, Vittor Cândido Soares6, Frederico Teixeira Izidorio, Juliana da Silva a Pereira, Marília de Andrade Salvá, Thamyres Veras Alves
https://creativecommons.org/licenses/by/4.0
https://ijn.zotarellifilhoscientificworks.com/index.php/ijn/article/view/379Wed, 28 Aug 2024 00:00:00 +0000The role of gut microbiota in the obesity: a literature review
https://ijn.zotarellifilhoscientificworks.com/index.php/ijn/article/view/378
<p><strong>Introduction:</strong> Obesity is a multifactorial and polygenic condition that, according to the World Obesity Federation, will affect over 1 billion people by 2030. In this regard, research is being conducted regarding gut microbiota influence on the pathogenesis of this disease, such as inflammation and insulin resistance. Therefore, understanding the gut microbiota and the mechanism by which its modulation through diet and/or the use of probiotics can impact the host and contribute to the treatment of obesity is essential. <strong>Methods:</strong> A systematic review was conducted on the PubMed, Scielo, and ScienceDirect databases, following the PRISMA protocol, from January 2018 to September 2022. <strong>Results and Conclusion:</strong> 415 articles were found. 36 studies were evaluated, and 20 were included in this review. The use of calorierestricting diets, along with the consumption of grains and cereals, was found to be useful in reducing strains that promote inflammation and insulin resistance, factors that are associated with obesity pathogenesis, leading to weight reduction. Other studies examined probiotics use, which led to lipopolysaccharides and insulin resistance reduction, as well as a decrease in the quantity of pro-inflammatory cytokines associated with obesity and type 2 diabetes mellitus. Therefore, combining diets with probiotic therapies may be a strategy for microbiota modulation, aiming to reduce inflammatory markers and insulin resistance.</p>Karen Thalyne Pereira e Silva Domingos, Vivian Menezes Irineu, Izabela Augusta de Oliveira Medeiros, Osmany Rodriguez Frometa, Marcelo José Diesel, Nathalia Galindo Cordeiro, Mirela Luna Santana Gomes, Cleanne Martins Silva, Douglas Stélio Lima Martins, Thiago Pegoretti Nogueira
Copyright (c) 2024 Karen Thalyne Pereira e Silva Domingos, Vivian Menezes Irineu, Izabela Augusta de Oliveira Medeiros, Osmany Rodriguez Frometa, Marcelo José Diesel, Nathalia Galindo Cordeiro, Mirela Luna Santana Gomes, Cleanne Martins Silva, Douglas Stélio Lima Martins, Thiago Pegoretti Nogueira
https://creativecommons.org/licenses/by/4.0
https://ijn.zotarellifilhoscientificworks.com/index.php/ijn/article/view/378Thu, 15 Aug 2024 00:00:00 +0000